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ABSTRACT 
 
Hematopoiesis is a well coordinated process which is regulated by the fine tuned 
interplay of several transcription factors. Hematopoietic stem cells (HSC) differentiate 
into lineage-committed progenitor cells which then give rise to distinct immune 
system cells. Langerhans cells (LC) are immune system cells located in the skin and 
their developmental pathway is absolutely dependent on the cytokine TGF-β1. 
However, still very little is known on the transcriptional control of LC differentiation. 
We identified the transcription factor Kruppel-like factor 4 (KLF4) to be inhibited by 
TGF-β1 in myeloid progenitor cells undergoing LC lineage commitment. Since LC 
share a common progenitor cell with monocytes/macrophages (Mo) and previous 
studies implicated KLF4 as a positive regulator of Mo development and CD14 
expression, we asked whether KLF4 is a critical factor in the control of LC 
differentiation. 
We used a well-defined human in vitro model of myelopoiesis and LC/DC subset 
differentiation to study KLF4 function. We found that LC lack KLF4 protein 
expression, whereas Mo or Mo-derived interstitial-type DC (DC) are KLF4 positive. 
Furthermore, our data reveals that ectopically expressed KLF4 significantly inhibits 
the surface expression of CD1a which is a LC/DC marker whereas it increases the 
Mo/DC marker CD11b. Ectopic KLF4 significantly decreases in vitro generation of LC 
from HSC, whereas it facilitates monocyte generation. Under DC culture condition 
KLF4 promotes an interstitial-type DC characterized by abundant CD11b and low 
CD1a expression. Moreover, ectopic KLF4 increases expression of the monocytic 
CD14 marker by cells cultured under LC generation conditions. In line with 
endogenous KLF4 in Mo, ectopic KLF4 failed to influence cell differentiation under 
optimal Mo culture condition. However, under suboptimal conditions, in the absence 
of M-CSF, KLF4 is able to restore Mo development by up-regulating the expression 
of CD11b as well as CD14. Since previous studies showed that LC and DC can be 
generated from CD14+ peripheral blood Mo, we also studied KLF4 in these cells. A 
combination of Delta-1, which is a ligand of the Notch signalling pathway, and TGF-
β1 is absolutely necessary to obtain LC characteristics from Mo. These Mo-derived 
LC lacked KLF4 protein whereas moDC generated in the presence of GM-CSF plus 
IL-4 showed abundant KLF4 protein expression. In these cultures TGF-β1 plus 
Delta-1 were strictly required for the repression of KLF4. In conclusion data suggest 
that KLF4 repression is a prerequisite for LC differentiation from monocytic cells. 
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ZUSAMMENFASSUNG 
 
Hämatopoiese ist ein Prozess, der durch das Zusammenspiel verschiedener 
Transkriptionsfaktoren und deren Expressions-Intensität, reguliert und gesteuert 
wird. Aus hämatopoietischen Stammzellen (HSC) entwickeln sich Vorläuferzellen, 
die dann wiederum zu bestimmten Immunsystemzellen ausdifferenzieren. 
Langerhans Zellen (LC) sind wichtige Immunsystemzellen in der Haut, welche in 
ihrer Entwicklung absolut anhängig von der Existenz des Zytokines TGF-β1 sind. Es  
ist allerdings noch nicht bekannt welche Transkriptionsfaktoren wichtig für deren 
Entwicklungsprozess sind. Wir untersuchten Transkriptionsfaktoren, die  downstream 
von TGF-β1 reguliert werden und fanden Kruppel-like Faktor 4 (KLF4) als signifikant 
inhibiert in myeloiden Vorläuferzellen. Da LC und Monozyten (Mo) einen 
gemeinsamen Vorläufer haben und von vorherigen Studien bekannt ist, dass KLF4 
eine positive Auswirkung auf die Entwicklung von Mo hat, stellten wir uns die Frage 
ob KLF4 einen wichtigen Faktor in der LC Differenzierung darstellt. 
Um die Auswirkungen von KLF4 zu testen, verwendeten wir ein in vitro Model zur 
myeloiden Differenzierung der verschiedenen Zelltypen. Wir stellten fest, dass LC 
KLF4 negative sind, wohingegen Mo und DC eine Expression von KLF4 aufwiesen. 
Ebenso zeigten unsere Versuche, dass ektopes KLF4 die Expression des LC/DC 
Markers CD1a signifikant inhibiert, wohingegen CD11b, ein wichtiger Marker für den 
DC/Mo Phänotypen, positive reguliert ist. Ebenso beobachten wir eine starke 
Reduktion der in vitro generierten LC Population, zu Gunsten eines Mo Phänotypen. 
Befanden sich die Zellen in DC Konditionen änderte sich deren Phänotyp, welcher 
eine starke CD11b und schwache CD1a Marker Expression zeigte. Weiteres stellten 
wir keine Änderung fest, wenn die Zellen unter optimalen Mo Bedingungen kultiviert 
wurden. Wird allerdings ein essentielles Zytokin für Mo, das M-CSF, weggelassen, 
konnten wir zeigen, dass ektopes KLF4 die Entwicklung der Mo wiederherstellen 
konnte. Da aus vorherigen Studien bekannt ist, dass man LC und DC aus CD14+ Mo 
generieren kann, analysierten wir auch hier die KLF4 Protein Levels. Wir 
beobachteten unter Delta-1, ein Ligand des Notch-Signaltransduktionsweges, und 
TGF-β1 Einfluss die Generierung von charakteristischen LC Merkmalen. Die 
Analysierung der Protein Levels in diesen Zellen zeigte, dass aus Mo generierte LC 
(moLC) KLF4 negativ sind, wogegen die moDC, welche mit GM-CSF und IL-4 
generiert wurden, KLF4 positive sind. In diesen Generierungsmodel ist ein 
Vorhandensein von Delta-1 und TGF-β1 absolut notwendig für die effiziente 
Inhibierung des KLF4. Letztendlich schließen wir aus unseren Daten, das KLF4 
Inhibierung notwendig ist um LC aus Mo Vorläuferzellen zu generieren. 
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1) Introduction 
 
1.1)  Progenitor Hierarchy from Hematopoietic Stem Cells – Myeloid 
Lineage Commitment 
 
Hematopoiesis is a developmental process which is used to describe the 
state of proliferation and differentiation of progenitor cells with ability of self-
renewal into distinct cell types. These differentiated cells are called 
hematopoietic stem cells (HSC) and they loose the ability for self-renewal 
once differentiate further into specialized cell types (Nerlov, Tenen and Graf, 
2001). This process is controlled by various factors which activate lineage-
specific genes and, therefore, restricting lineage commitment (Tenen et al, 
Blood 1997) which is explained later. There are two separate lineages of 
mature blood cells: the lymphoid and the myeloid. The lymphoid lineage gives 
rise to B-, T- and natural killer-cells (NK) whereas the myeloid lineage leads 
to differentiation into various granulocyte (Gr) subsets (neutrophils, basophils 
and esinophils), erythrocytes, mast cells, megakarytrocytes and monocytes 
(Mo), which later differentiate into macrophages (Mac; Figure 1). Dendritic 
cells (DC) can be produced from both the lymphoid and the myeloid lineage 
(Manz et al, Blood 2001). It was shown experimentally that the common 
lymphoid progenitors (CLP) are restricted in their ability to differentiate into 
any lymphoid lineage cells, whereas the common myeloid progenitors (CMP) 
are able to give rise to any of the myeloid lineage cell types (Kondo et al, Cell 
1997; Akashi et al, Nature 2000). 
 
DC have a crucial role as antigen presenting cells (APC), which is a specific 
category of cells of the immune system specializing in capture, processing 
and presenting of antigens to T cells. DC are very important during bacterial 
or viral infections as well as for T-cell immunity against tumors. DC are also 
thought to play an important role in controlling the balance between immunity 
and immunological tolerance. Upon encounter with any microbial product 
immature DC initiate maturation and migrate to lymph nodes where they 
present the microbial antigen to T-cells. Apart from T cells, DC can also 
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interact with other cell types like B- or NK-cells as well as remain in the tissue 
as inflammatory mediators than migrate to the lymph nodes. It is conceivable, 
therefore, that there are different subsets of DC to account for such range in 
their functions (Shortman et al, Nat Rev Immunol. 2002). In human there are 
three known main DC subtypes with various functions under steady state 
conditions: epidermal Langerhans cells (LC) which represent the classical DC 
life and are present in the skin as “first” immunological barrier (Romani et al, 
APMIS. 2003); tissue/interstitial/dermal DC which are found in the tissues 
such as epithelia of the intestinal, respiratory and reproductive tract and will 
be called only DC; and plasmacytoid DC (pDC) which are present in the 
blood, able to produce large amounts of type I interferons and play an 
important role in the immune response to viruses (Liu YJ, Annu Rev Immunol. 
2005). During inflammation an additional DC subset appears which is called 
myeloid dermal “inflammatory” DC (Shortman et al, Nat Rev Immunol 2007). 
 
 
 
Figure 1 : Schematic model of lineage differentiation (according to the 
model by Rosenbauer et al, Nature 2007).   
Hematopoietic stem cells (HSC) are cells with self renewal potential and give rise 
to multipotential progenitors (MPP). Those progenitors lose the self-renewal 
potential but still retrain the ability to differentiate into various different cell 
lineages. There are two main common progenitors described: The common 
lymphoid progenitors (CLP) are thought to develop B and T cells whereas the 
common myeloid progenitors (CMP) produce granulocyte/macrophage 
progenitors (GMP), megakaryocyte/erythroid progenitors (MEP) and also a 
macrophage and dendritic-cell progenitor (MDP). In our study the focus is set on 
the myeloid lineage commitment with the development of granulocytes, 
monocytes and dendritic cells (indicated by the black arrows). 
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1.1.1)  Different DC Subsets in Steady State and Inflammation 
 
LC are characterised by the expression of Langerin (CD207), E-cadherin and 
cluster of differentiation 1a (CD1a). Langerin is a membranous C-type lectin 
(Valladeau et al, Immunity. 2000) that is responsible for the formation of 
Birbeck granules. CD1a represents a major histocompatibility complex I-like 
molecule that presents antigens to T-cells (Barral et al, Nat Rev Immunol. 
2007). LC have a long lifespan in the skin where they are in close contact with 
keratinocytes and they migrate to the lymph nodes under steady state 
conditions only at a base rate. The migration rate of LC is increased during 
inflammation or in the presence of other microbial stimuli (Kissenpfennig et al, 
Immunity. 2005). In mouse Mo (“inflammatory” Mo, see chapter 1.2.2) seem 
to be effective as LC precursors after LC depletion in the skin (Ginhoux et al, 
Nat Immunol. 2006). An important requirement is the expression of the 
chemokine receptor 2 (CCR2) for the recruitment of Mo from the bone 
marrow to the skin (Serbina et al, Nat Immunol. 2006). In humans there is 
also a distinct Mo subset which has been shown to be an effective LC 
precursor and it expresses CCR2 (Schaerli et al, Immunity 2005). Up to date 
the function of LC was closely studied following the induction of inflammation, 
leaving open the question how the steady state LC develop. It is important to 
note that in mice lacking the macrophage colony-stimulating factor receptor 
(M-CSFR), LC are completely absent which leads to the strong indication that 
Mo might be the real precursors for LC even under steady state conditions 
(Ginhoux et al, Nat Immunol. 2006).  
 
In contrast to LC interstitial DC (also known as dermal DC) lack the 
expression of Langerin, they do not form Birbeck granules and are obtained 
from CCR2- Mo. Upon the uptake of antigens they mature and migrate to the 
draining lymph nodes to present these antigens to B- and T-cells (Nestle et al, 
J Invest Dermatol. 1998). These dermal DC can be further divided into 
“resident” dermal DC and a second population which appears after 
inflammation, the so called “inflammatory” dermal DC (Shortman et al, Nat 
Rev Immunol 2007). Under steady state these “resident” dermal DC are 
immature and exhibit modest T-cell stimulatory activity (Zaba et al, J Clin 
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Invest. 2007). Their potential to migrate to the lymph nodes might be 
explained by the fact that they express CCR7 and are, therefore, responsive 
to the lymph node chemokine CC chemokine ligand 19 (CCL19; Angel et al, J 
Immunol. 2006). Circulating DC precursors may give rise to these 
“inflammatory” dermal DC after migration into the skin because of 
inflammatory signals. In certain cases of skin diseases (e.g. psoriasis) these 
DC have been termed tumor necrosis factor and inducible nitric oxide 
synthase-producing DC (Tip-DC) because of their potential to produce 
inflammatory mediators like TNFα and iNOS (Lowes et al, Proc Natl Acad Sci 
USA 2005). In human these Tip-DC are found in the lamina propria of the gut. 
They seem to be important for the production of Immunoglobulin A (IgA; 
Tezuka et al, Nature 2007) and the stimulation and differentiation of Th17 
cells which show an association in many autoimmune inflammations (Zaba et 
al, J Invest Dermatol. 2009). These DC seem to act as a source of 
inflammatory mediators rather than following the classical role of a DC as an 
APC. They are also involved in autoimmune inflammation and there is a 
strong interest in understanding the developmental and activation process of 
these cells. 
 
Plasmacytoid DC (pDC) share many similarities with B-cells. For instance, 
pDC also depend on certain B cell transcription factors (e.g. Spi-B). pDC are 
characterized by their production of large amounts of type I interferons (i.e. 
IFNα, β, ω) during viral infections (Liu et al, Annu Rev Immunol 2005). IFNα 
modulates the differentiation of various cell types, including T-cells and 
myeloid DC. In the normal skin the numbers of pDC are low, whereas 
markedly elevated cell numbers of pDC are found in psoriasis. Blocking of 
IFNα has been shown to prevent psoriasis, which leads to the suggestion that 
pDC might be causally implicated in the pathogenesis of psoriasis (Nestle et 
al, J Exp Med. 2005). The keratinocytes peptide LL37 is able to induce IFNα 
production in pDC (Lande et al, Nature. 2007) and it has notable higher 
expression levels during inflammation (e.g. psoriasis). It is, therefore, 
plausible that in psoriasis these pDC are extra sensitive and tend to respond 
to inflammation by overproduction of IFNα. 
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1.1.2)  Master Transcription Factors and Cytokines in the 
Development of Dendritic Cells and Monocytes 
 
Transcription factors play an important role in hematopoiesis and 
development of distinct cell types. They lead to the expression of 
characteristic lineage-specific target genes driving the precursor cell into a 
specific differentiation program. The interplay of these transcription factors 
and their expression levels are important for the determination of cell fate 
during their differentiation process (Orkin SH, Nat Rev Genet. 2000).  
 
Early myeloid progenitors and common lymphoid progenitors are dependent 
on PU.1 (Tenen et al, Blood 1997). PU.1 knockout mice reveal a complete 
absence of B-cells and Mac (McKercher et al, EMBO J 1996). Interestingly, 
high levels of PU.1 support Mac development whereas low levels support the 
production of Gr (Dahl et al, Nature Immunol 2003). CCAAT/enhancer binding 
protein α (C/EBPα) is required for the production of granulocyte/macrophage 
progenitors (GMP) from common myeloid progenitors and, therefore, for 
granulopoiesis in general (Radomska et al, Mol Cell Biol 1998). The 
differentiation into Mac or Gr from the GMP is controlled by PU.1 and one of 
its protein binding partners, the interferon-γ (IFNγ)-responsive transcription 
factor also called IRF8. IRF8 is expressed by B-cells, DC and Mac but not by 
Gr (Tamura et al, Immunity 2000). GFI1 and C/EBPε are required for Gr 
development after reaching the GMP state (Laslo et al, Cell 2006; Yamanaka 
et al, Proc Natl Acad Sci USA 1997). GFI1-deficient mice show a defect in 
lymphoid progenitor development and they lack neutrophilic Gr (Hock et al, 
Immunity 2003). Retinoic acid receptor (RAR) is also implicated in 
granulopoiesis since its inhibition leaves the cells at the promyelocyte stage 
(Tsai et al, Proc Natl Acad Sci USA. 1993). RAR heterodimerizes with the 
retinoid X receptor (RXR) proteins. Addition of a combination of retinoic acid 
(RA) and vitamin D induces monocytic development by activation of vitamin D 
receptor (VDR):RXR complexes which bind and repress RAR:RXR 
responsive elements (Bastie et al, Mol Endocrinol 2004). It is the interplay of 
GFI1, IRF8 and the expression level of PU.1 as well as the complex formation 
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with either VDR or RAR that determine the developmental pathway towards 
either Mac or Gr. 
 
STAT3 which is a transcription factor downstream of Fms-like tyrosine kinase 
3 (FLT3) signaling seems to be an important factor for DC since its deletion 
leads to reduced DC development (Laouar et al, Immunity 2003). On the 
other hand, Ikaros is shown to be a necessary factor for DC generated from 
common lymphoid progenitors. Ikaros-/- mice lack B-, T-, NK-cells and their 
DC subsets, whereas LC and cells from the erythroid and myeloid lineage are 
unaffected (Wu et al, Immunity 1997). PU.1 is highly expressed in DC and is 
required for DC development especially for monocyte-derived DC (Guerriero 
et al, Blood 2000). Additionally relB seems to have an important function in 
developing LC/DC/Mo progenitors which differentiate further into DC. 
Blocking this pathway results in impaired moDC development but has no 
effect on the LC pathway (Platzer et al, Blood 2004). A strong influence on 
DC development is exerted by IFN-regulatory factors (IRFs). IRF8-/- mice 
show a severely reduced number of pDC whereas IRF4-/- mice have only 
some reduction in the pDC counts (Tamura et al, J Immunol 2005). In IRF8- 
and IRF2-deficient mice are reported to have a decreased number of LC 
(Schiavoni et al, Blood 2004). Another factor necessary for pDC development 
is the Ets-domain transcription factor Spi-B. This has been shown by RNA 
interference-mediated gene knockdown of Spi-B mRNA which results in 
diminished pDC and enhanced B-cell and myeloid cell development (Schotte 
et al, J Exp Med 2004). Additionally, the inhibitor of DNA binding Id2 which is 
a member of the inhibitory helix-loop-helix (HLH) factors is essential for DC 
and LC development. Id2 inactivation shows increased numbers of pDC 
(Hacker et al, Nat Immunol 2003). On the other hand, activation of HLH 
factors such as E2A or HEB stimulates pDC development (Schotte et al, J 
Exp Med 2004) leading to the conclusion that multiple factors and their 
interactions are important for determination of cell fate and pDC 
differentiation. The LC pathway and its developmental origin are more 
complicated, although, much is known about activation of LC and their 
trafficking towards the lymph nodes. It is known that LC differentiation is 
dependent on transforming growth factor (TGF) β1 (Strobl et al, J Immunol 
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1996). TGF-β1 induces Id2 which antagonizes the activating HLH factors like 
E2A and, therefore, represses B-cell genes (Hacker et al, Nat Immunol 2003). 
Removal of either TGF-β1 or Id2 leads to a loss of LC. RunX3 expressed in 
mature DC is another important player as a mediator of TGF-β1 response. 
RunX3-/- mice lacks LC (Fainaru et al, EMBO J 2004). As mentioned earlier, 
LC numbers are decreased in IRF8-/- and are notably increased in Gfi1-/- mice 
(Rathinam et al, Immunity 2005). A short overview of the transcription factors 
in the different lineages is shown in Figure 2A. 
 
 
 
Figure 2: Important transcription factors and cytokines in the development 
of different myeloid cells as well as DC from lymphoid progenitors.  
A) As indicated in the text PU.1 is absolutely necessary for early progenitor cell 
development in the myeloid as well as the lymphoid lineages (Tenen et al, Blood 1997). 
The different expression levels of PU.1 play an important role in subsequent 
differentiation steps: low PU.1 levels lead to Gr differentiation whereas high levels are 
obtained in Mac and DC. Also important for Gr is C/EBPε, conversely IRF8 forces Mac 
development from the GMP state. Id2 is necessary for DC and LC whereas it inhibits 
pDC development. An essential factor for pDC is Spi-B. DC differentiation from CLP 
cells is dependent on Ikaros. The interplay of different factors and their expression level 
are important for determining cell fate and decision. B) There are different important 
cytokines to obtain the various lineages from hematopoietic progenitors. TGF-β1 is an 
absolutely necessary cytokine for LC differentiation whereas M-CSF induces Mac and 
G-CSF induces differentiation from GMP into Gr. 
 
 
An important cytokine for DC development from hematopoietic precursors or 
Mo in vivo is granulocyte-macrophage colony-stimulating factor (GM-CSF; 
Caux et al, Nature 1992; Sallusto et al, J Exp Med 1994), despite the fact that 
mice lacking GM-CSF or its receptor (GM-CSFR) display no effects on the 
Introduction 
 
 - 8 -  
developmental pathway of DC (Vremec et al, Eur J Immunol 1997). GM-CSF 
is not detectable in steady state conditions but increases under inflammatory 
circumstances (Hamilton JA, Nat Rev Immunol 2008) which lead to the 
suggestion that it might be a crucial factor for DC differentiation during 
inflammation. Also important to mention is that GM-CSF leads to STAT3 
activation and IRF4 expression (Esashi et al, Immunity 2008) which are 
required for DC differentiation. Fms-like tyrosine kinase 3 ligand (Flt3L) plays 
a key role in the DC differentiation because its inhibition results in a decrease 
of DC and pDC numbers but interestingly reveals no affects on LC (McKenna 
et al, Blood 2000, Merad M. and Manz MG, unpublished data, January 2009). 
Tumor necrosis factor-α (TNFα) in combination with GM-CSF is necessary to 
obtain DC in vitro. When these cells are further cultured with TGF-β1 they 
develop LC characteristics, whereas Interleukin 4 (IL-4) induces DC (Caux et 
al. J. Exp. Med. 1996). An important finding was that TGF-β1 is one of the un-
redundant cytokines necessary for LC differentiation in human as well as in 
mice (Strobl et al, J Immunol. 1996; Borkowski et al, J Exp Med 1996) and 
delivers the upstream signal for Id2 which is an important factor for LC 
development as referred to before (Hacker et al, Nat Immunol 2003). 
Macrophage colony-stimulating factor (M-CSF) is an important cytokine for 
several Mac populations as it is exhibited in mice lacking M-CSF or its 
receptor (M-CSFR). Those mice reveal a total absence of osteoclasts and 
therefore develop osteoporosis (Dai et al, Blood 2000). M-CSF is detectable 
in steady state condition but increases after inflammation (Hamilton JA, Nat 
Rev Immunol 2008). As mentioned before it is interesting that LC 
differentiation seems to be indispensable on M-CSFR because mice lacking 
M-CSFR show an absence of LC and it is indicated that a special Mo subset 
repopulates LC in inflamed skin in a M-CSFR manner (Ginhoux et al, Nat 
Immunol 2006). This and all the possible generation models to obtain DC or 
LC from a CD14+ precursor cell will be discussed later (chapter 1.2.2). Last 
but not least an important cytokine for Gr differentiation in vivo is the 
granulocyte colony-stimulating factor (G-CSF). A short overview on cytokines 
that determine myeloid/DC sublineage differentiation from human CD34+ 
progenitor cells is shown in Figure 2B. 
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1.1.3)  Characteristic Marker Expression of the Different Lineages 
 
The diverse cell types can be distinguished by their expression of various 
markers. There are many different markers extra- as well as intracellular. 
Here only those markers will be mentioned which are relevant to the following 
experiments. As mentioned before LC are characterized by their surface 
expression of CD207, CD1a and E-cadherin. DC by contrast co-express 
CD11b and CD1a surface marker in the absence of E-cadherin. Mo are 
identified by high CD14 surface expression and CD11b, whereas Gr show 
expression of intracellular Lactoferrin (LF) and Myeloperoxidase (MPO) 
expression as well as surface expression of CD15 and CD11b (Figure 3). 
 
 
 
 
 
Figure 3: Marker expression of the different lineages.   
LC are characterized by CD207 expression whereas this molecule is absent from all 
other lineages. Mo are indicated by high CD14 expression and Gr show intracellular 
LF and MPO as well as surface expression of CD15. E-Cadherin (E-Cad); Lactoferrin 
(LF); Myeloperoxidase (MPO). 
 
 
1.2) Monocyte Heterogeneity 
 
About 5 to 10% of the peripheral blood leukocytes in mouse and human 
represent monocytes. They are short-lived and believed to continuously 
repopulate Mac and DC populations. Therefore they fulfil critical roles in 
innate and adaptive immunity in steady-state as well as during inflammation 
(Ziegler-Heitbrock, J Leukoc Biol 2000). They are characterized by their 
expression of CD11b, CD11c and the lipopolysaccharide (LPS) receptor 
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(CD14) in human and CD11b and F4/80 in mice. Moreover they lack the 
expression of B, T, NK and DC markers.  
 
1.2.1)  Two Different Main Monocyte Subsets in Human and Mouse 
 
Human Mo subsets can be divided into “classical” with high CD14 and no 
expression of the Fc receptor CD16 (~90% of the total human Mo) and into 
“proinflammatory” Mo which are CD14 and CD16 positive (Passlick et al, 
Blood 1989). It has been shown that the expression of CD16 can be induced 
by the cytokines M-CSF, IL10 and TGF-β1 (Wahl et al, J Immunol 1992; 
Calzada-Wack et al, J Inflamm 1996). Conversely, CD14 expression seems 
to be reduced by TGF-β1, but up-regulated by IL-10. In addition to the 
expression of CD16 the “pro-inflammatory” Mo subset lacks the expression of 
receptors for inflammatory cytokines [CC chemokine receptor 1 (CCR1), CXC 
chemokine receptors 1 (CXCR1) and CXCR2]. However  they express high 
amounts of major histocompatibility complex (MHC) class II [is found on 
antigen presenting cells (APC)] and CD32 which acts to modulate B cell 
signalling (Geissmann et al, Immunity 2003; Weber et al, J Leukoc Biol 2000; 
Gordon et al, Nat Rev Immunol. 2005). 
 
It has been shown that CD14+/CD16+ proinflammatory Mo produce high 
levels of the proinflammatory cytokine TNFα and low levels of anti-
inflammatory IL-10 after LPS stimulation (Frankenberger et al, Blood 1996). 
Furthermore they can rapidly migrate to the site of inflammation and 
differentiate into tissue Mac there (Ziegler-Heitbröck et al, Eur J Immunol. 
1993). However both subsets are able to differentiate into DC; the CD16+ 
subset shows a higher predisposition for DC (Grage-Griebenow et al., Eur. J. 
Immunol. 2001; Randolph et al., J. Exp. Med. 2002) whereas the CD16- 
subset has a propensity to develop into LC (Schaerli et al, Immunity 2005). 
Surface marker molecules expressed by Mo subsets are depicted in Table 1. 
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Table 1: Surface expression markers on the two different Mo subsets in 
human. Adapted from Strauss-Ayali et al, J Leukoc Biol. 2007 and Tacke et al, 
Immunobiology. 2006. ND, not determined 
Human Mouse surface marker 
expression CD14+ CD16+ CD14++ CD16- Gr1low Gr1high 
     
CD11b + + + + 
CD14 + High ND ND 
CD16 (FcγRIII) + - + + 
CD32 + High + + 
CD43 High + + - 
CD49b ND ND + - 
CD62L (L-Selectin) - + - + 
CD64 (FcγRI) - + ND ND 
CD163 - ++ ND ND 
CCR1 - + ND ND 
CCR2 - + - + 
CCR4 - + ND ND 
CCR5 High - + - 
CCR6 ? ? ? ? 
CCR7 - + ND ND 
CXCR1 and 2 - + ND ND 
CX3CR1 High Low ++ + 
F4/80 ND ND + + 
Ly6C(Gr1) ND ND - + 
MHC Class II High + - - 
 
 
For the selective recruitment of leukocytes to the site of inflammation, 
chemokines and their receptors are necessary (Baggiolini et al, Nature 1996). 
The CD16+ population shows impaired transendothelial chemotaxis and 
migration after monocyte chemotactic protein-1 (MCP-1) stimulation. In 
contrast to classical Mo, this subset fails to up-regulate CD11b in response to 
MCP-1 due to the fact that they have no expression of the receptor CCR2. 
CD11b is an essential molecule for Mo adhesion to endothelial cells. 
However, they show more pronounced up-regulation of CD11b in response to 
macrophage inflammatory protein-1α (MIP-1α) which binds the receptor 
CCR5 (Weber et al, J. Leukoc. Biol. 2000). In addition to this, the CD16+ 
subset expresses higher levels of CX3CR1, a receptor that is important for 
mediating both leukocyte migration and leukocyte firm adhesion (Imai et al, 
Cell 1997). Fractalkine (FKN) is the ligand for CX3CR1 and is activated by 
proinflammatory cytokines such as TNFα (Imaizumi et al, J Atheroscler 
Thromb. 2004). Interestingly, CX3CR1 seems to be up-regulated by IL-10 
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(Yano et al, Acta Med Okayama. 2007) as is CD16 (which additionally needs 
TGF-β1). Interestingly both of these cytokines are present for example in the 
inflamed joints of rheumatoid arthritis (RA). It is shown that in many 
inflammatory diseases, like RA (Kawanaka et al, Arthritis Rheum. 2002), 
atherosclerosis (Hakkinen et al, Virchows Arch. 2000), asthma (Rivier et al, 
Exp. Immunol. 1995), peridontitis (Nagasawa et al, J. Periodontal Res. 2004) 
and others the CD16+ subset is significantly increased. Also in bacterial and 
HIV infections as well as in cancer the CD16+ CD14+ subset is increased 
(Fingerle et al, Blood 1993; Pulliam et al, Lancet 1997; Saleh et al, Blood 
1995). 
 
The CD16+/CD14+ proinflammatory Mo subset has further been divided into 
two populations; one is CD14high CD16+ and the other is CD14dim CD16+ 
(Passlick et al, Blood 1989). These two populations seem to have different 
phenotypes and functions: The CD14high subset shows higher CD11b and 
TLR4 expression as well as a higher IL-10 production after LPS stimulation 
than the CD14+ CD16+ and CD14+ CD16- subsets although the TNFα 
production is the same compared with the CD14+ CD16+ subset. Therefore 
this CD14high CD16+ subset seems to be rather an anti-inflammatory than a 
proinflammatory subset (Skrzeczyn´ska-Moncznik et al, Scand J Immunol. 
2008). 
 
Also in mouse two different Mo subsets are described. They were first divided 
based on the different expression of CX3CR1 (Palframan et al, J Exp Med 
2001) and later by the expression of Ly6C (Gr-1) (Geissmann et al, Immunity 
2003). Similar to the “classical” human Mo the Ly6C+ subset is CCR2+ 
CX3CR1+ CD62L+, whereas the Ly6C- Mo, that equal the human the 
“proinflammatory” subset, are CCR2- CX3CR1++ CD62L- (Palframan et al., J 
Exp Med 2001; Geissmann et al., Immunity 2003; Sunderkotter et al., J. 
Immunol. 2004). Geissmann et al. defined the CX3CR1low Ly6C+ as 
“inflammatory” Mo subset which is short-lived and represents a circulating 
precursor for dendritic and myeloid cells at inflammatory sites.  The second 
CX3CR1high Ly6C- subset, the so called “resident” Mo was proposed to persist 
longer and represent a precursor in noninflamed tissue. In strong contrast to 
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the human system where the CD14+ CD16+ subset is expanded during 
infections in the mouse it is the Ly6Chigh population which is elevated during 
an inflammation process. In Figure 4A-C a short summary of the different 
human and mouse subsets is shown. 
 
 
 
 
Figure 4: Human and mouse Mo subsets.  
There exist two different Mo subsets in human and mouse. They show different 
surface receptor expression and migratory behaviour. A) The human proinflammatory 
subset, characterized by the expression of CD16, shares many features with the 
mouse resident subset that lacks the expression of Ly6C. They are smaller in size, 
less granular and both express CCR5 but lack the expression of the inflammatory 
chemokine receptors CCR1, CXCR1 and CXCR2. Due to the higher CX3CR1 
expression the CD16+ subset can migrate easier across endothelial monolayer 
(Randolph et al, J. Exp. Med 2002). It furthermore seems to be a survival signal for 
the Ly6C- subset. The second subset also called classical (human) or inflammatory 
(mouse) Mo, expresses CCR2 and therefore is rapidly recruited to inflamed tissue. 
These cells seem to be involved in innate inflammatory response in contrast to the 
first subset, which has been implicated in tissue homeostasis. In human the classical 
Mo give rise to moLC (Larregina et al, Nat Immunol. 2001) whereas in mouse the 
inflammatory Mo seem to be direct LC precursors (Ginhoux et al, Nat Immunol. 
2006). B) A FACS analysis of the human Mo subsets. The FACS diagram shows the 
different expression pattern of CD16 and CD14 by Ziegler-Heitbröck, J.Leukoc. Biol. 
2007. C) Ly6C expression in murine Mo subsets as shown by Tacke et al, 
Immunbiology 2006. 
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1.2.2)  Are Monocytes Potential Progenitors of Langerhans Cells? 
 
In human LC are characterised by the expression of CD207, E-cadherin and 
CD1a and lack of CD14 expression. The mechanisms how LC precursors 
migrate to the epidermis are not well understood but it is thought that a bone 
marrow-derived myeloid precursor traffics somehow into the overlaying 
epidermis. Macrophage inhibitory protein-3α (MIP-3α) also known as CCL20 
which is a ligand for CCR6 seems to be important for that (Charbonnier et al, 
J Exp Med. 1999). In normal human skin CCL20 is low. However under 
inflammatory conditions it is highly up-regulated (Moser et al, Trends 
Immunol. 2004). Interestingly it has been shown that IL-10 induces the 
expression of CCR6 whereas the moDC cytokine IL-4 represses it (Dieu-
Nosjean et al, J Immunol 2001). Furthermore it was shown that the 
expression of the CCR6 ligand MIP-3α is provoked by TNFα and produced by 
keratinocytes (Tohyama et al, J Dermatol Sci 2001). Both, TNFa and MIP-3a 
can also be produced by the human CD14high CD16+ proinflammatory Mo 
subset (Skrzeczyn´ska-Moncznik et al, Scand J Immunol 2008). 
 
Studies showed that there exists a population of human CD14+ cells which 
actively migrates in response to MIP-3α and which exhibits immature LC 
characteristics after short term cultivation with TGF-β1 (Larregina et al, Nat 
Immunol 2001). When these migratory CD14+ (miCD14+) cells are cultured 
with M-CSF they undergo cell death whereas peripheral blood Mo 
differentiate into Mac (Larregina et al, Immunology 1997). The miCD14+ cells 
express CCR6 which is the receptor for the ligand MIP-3α and which is also 
present on LC. Larregina et al. postulated the suggestion that these miCD14+ 
cells migrate into the epidermis in response to MIP-3α and differentiate to 
immature LC under the influence of TGF-β1; under inflammatory conditions 
containing GM-CSF with or without IL-4 the cells further differentiate into 
mature LC which have an enhanced potential for T cell stimulation. However 
it has not been shown yet that this miCD14+ cells represent the CD16+ or 
CD16- proinflammatory Mo subset.  
Schaerli et al. postulated that CXC motif chemokine ligand-14 (CXCL14) 
seems to be important for LC differentiation because unlike CCL20 it is 
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present in the skin under steady state conditions and is not up-regulated 
further in skin diseases. In the skin it is selectively expressed in blood vessels 
of the superficial dermal plexus and in the epidermis. It has been shown that 
CXCL14 selectively attracts CD14+ cells but no other myeloid cells like moDC 
or LC. In this study it was furthermore indicated that the CD16+ inflammatory 
Mo subset shows limited chemotaxis towards CXCL14. Therefore under 
steady state conditions it is more likely that the classical CD14high CD16- Mo 
subset is the one which migrates into the skin and acquires LC characteristics 
(Schaerli et al, Immunity 2005).  
 
In a mouse model it was, however, shown that the CXCL14 is dispensable for 
homeostatic recruitment of DC-like cells to the skin (Meuter et al, Mol Cell Biol 
2007). It was furthermore demonstrated that in mouse the recruitment of LC 
precursors after UV-light induced skin inflammation is absolutely dependent 
on the expression of CCR2 (Merad et al, Nat Immunol 2002). In accordance 
with this, Ginhoux et al. demonstrated that in mouse the Ly6C+ Mo subset 
which also expresses CCR2 is a direct precursor for LC. They furthermore 
could show that this process is depended on colony-stimulating factor-1 
receptor (CSF-1R=M-CSFR; Ginhoux et al, Nat Immunol 2006). Therefore in 
mouse it is rather the “inflammatory” subset which gives rise to LC, whereas 
in humans is rather “classical” Mo subset that develops to LC (Figure 5). 
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Figure 5: Schematic representation of the differentiation from Mo into 
LC.  
In human as well as in mouse the Mo population is heterogeneous (Passlick et al, 
Blood 1989; Geißman et al, Immunity 2003). It is indicated that these subsets differ in 
their migratory behaviour as well as in their surface marker expression. In human it is 
has been shown that MIP-3α is released by epithelial cells. It was therefore 
suggested that it is one of the signals that recruits LC precursors to the skin 
(Charbonnier et al, J Exp Med 1999). Larregina et al. shows that miCD14+ cells 
express CCR6 the receptor for MIP-3α and therefore traffic into the epidermis where 
they develop LC characteristics. Schaerli et al. however postulated that CXCL14 is 
also required for this process. They furthermore could show that only the CD14+ and 
not so much the CD16+ Mo subset responds to this ligand. In contrast to the human 
system CXCL14 shows no relevance in regulating this recruitment in mouse (Meuter 
et al, Mol Cell Biol 2007). Here CCR2 as well as M-CSFR (CSF-1R) are believed to 
be absolutely necessary for the recruitment of LC progenitors into the skin (Merad et 
al, Nat Immunol 2002; Ginhoux et al, Nat Immunol. 2006). Consequently the mouse 
Mo subset which represents the counterpart of the human Mo subset does not only 
show similar surface expression but also seems to possess same LC precursor 
potential. Interleukin-10 (IL-10); tumor necrosis factor (TNF); CC chemokine receptor 
(CCR); CC chemokine ligand (CCL); macrophage inhibitory protein-3α (MIP-3α); 
CXC motif chemokine ligand-14 (CXCL14); monocyte chemoattractant protein-1 
(MCP-1); colony-stimulating factor-1 receptor (CSF-1R) is equivalent to M-CSFR. 
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1.2.3)  Generation Model for Monocyte-derived Dendritic Cell Types 
 
A generation model to obtain monocyte-derived DC (moDC) in vitro is well 
established. This model uses the cytokines GM-CSF and IL-4 to induce DC 
from monocytic precursors (Chapuis et al, Eur J Immunol 1997). Also other 
cytokines are now discovered to induce DC differentiation from a CD14+ Mo.  
 
TNFα gives rise to a special moDC-like phenotype. This moDC like cells have 
monocytic characteristics but additionally express the DC marker CD1a. It 
has been shown that this moDC are able to evoke T helper cells 1 (Th1) and 
Th17 response (Iwamoto et al, J Immunol. 2007). It has also been shown that 
addition of IL-15 to such monocytic cells leads to the development of a CD1a 
positive cell population that looses CD14. In addition half of the population 
gains CD11b. Interestingly these cells also became CD207 positive 
(Mohamadzadeh et al, J Exp Med 2001). Furthermore IFNα stimulation also 
induces the development of CD1a positive cells (Santini et al, J Exp Med 
2000).   
 
In addition to the generation of moDC from Mo, prior studies from Geissmann 
et al. indicate that it is also possible to generate cells with LC characteristics 
from CD14+ Mo under GM-CSF, IL-4 and TGF-β1 conditions (Geismann et al, 
J Exp Med 1998). Both cytokine, TGF-β1 and GM-CSF are also present in the 
skin in vivo. TGF-β1 is produced by keratinocytes in the epidermis (Sporn et 
al, J. Cell Biol 1992) and GM-CSF by a variety of cells which populate the 
skin (Pastore et al, Clin Invest 1997). Relating to Geismann’s study it was 
furthermore shown by another group (Hoshino et al, J Leukoc Biol 2005) that 
GM-CSF, TGF-β1 and Notch ligand Delta-1 are required for LC differentiation 
from CD14+ Mo (Figure 6). The group could furthermore show that Delta1, 
which is involved in Notch signalling, and is as well as TGF-β1 and GM-CSF 
present in the skin environment in vivo (Hoshino et al, J Leukoc Biol 2005; 
Lowell et al, Curr Biol 2000). 
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Figure 6: Generation model of monocyte-derived dendritic cell types 
under different conditions.   
When isolated Mo are cultivated in special conditions they acquire DC 
characteristics. The best established model is the generation of moDC with GM-CSF 
and IL-4 (Chapuis et al, Eur J Immunol 1997) but until now also other cytokines were 
shown to induce DC differentiation from Mo. Those cytokines include TNFα (Iwamoto 
et al, J Immunol 2007), which was shown to induce moDC with monocytic features, 
IL-15 which also is able to induce CD207 expressing moLC (Mohamadzadeh et al, J 
Exp Med 2001) and IFNα, which was shown to induce moDC like cells (Santini et al, 
J Exp Med 2000). Prior studies also indicated that cells with LC characteristics can 
be generated from Mo using GM-CSF, IL-4 and TGF-β1 (Geismann et al, J Exp Med 
1998). These findings were extended by the finding that Delta-1, TGF-β1 and GM-
CSF lead to the differentiation of moLC with the expression of CD1a and CD207 
(Hoshino et al, J Leukoc Biol 2005; Lowell et al, Curr Biol 2000).  
 
 
Notch signalling regulates a broad spectrum of cell fate decisions (Artavanis-
Tsakonas et al, Science 1999). The Notch family consists of four receptors, 
Notch-1 to 4, and five ligands, Jagged-1 and -2 and Delta-1, -3 and -4. It is 
indicated that activation of Notch signaling regulates proliferation and 
differentiation of hematopoietic stem cells and that in the hematopoietic 
system especially Delta-1 family are the predominant ligands involved (Ohishi 
et al, J Clin Invest 2002). Interestingly it is shown that Mo express high 
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amounts of the Notch receptors. Signalling via those receptors inhibits the 
survival of Mo in presence of M-CSF but not when GM-CSF is available and 
permits their differentiation into DC (Figure 7). For this reason it was 
proposed that Notch signalling inhibits Mac differentiation, but promotes DC 
development from monocytic precursors (Ohishi et al, Blood 2000 and 2001). 
It was furthermore shown that LC generated with Delta-1, TGF-β1 and GM-
CSF from CD14+ Mo seem to correspond to immature LC. Those cells show 
phagocytic activity and migrate in response to MIP-3α, which are functional 
properties of immature LC. (Hoshino et al, J Leukoc Biol 2005). As already 
mentioned before, TGF-β1 is sufficient to induce LC development from 
haematopoietic progenitors in vitro. However for the differentiation of LC from 
Mo additional signalling via Delta1-Notch is needed. It is interesting in this 
respect that several reports have shown that TGF-β1 and Notch 
synergistically regulate common target genes in various cell types. It is 
therefore interesting to speculate that while TGF-β1 alone is sufficient to 
induce LC differentiation from mulitpotent progenitors, TGF-β1 and Notch 
signalling have to act synergistically to induce the development of LC from 
fully differentiated Mo. 
 
 
 
Figure 7: Notch signalling via Delta-1 is important for LC differentiation.  
Mo express a high amount of Notch receptors. In response to Delta-1 stimulation 
they develop DC-like characteristics under GM-CSF influence whereas under M-CSF 
they undergo cell death. If additionally TGF-β1 is present they are able to 
differentiate into LC (Hoshino et al, J Leukoc Biol 2005). 
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1.3) Kruppel-like Transcription Factors  
 
 
The gene regulatory protein family Kruppel-like factor (KLF) is named after 
the embryonic pattern regulator Kruppel in Drosophila because they show 
homology with the DNA binding domains. This family of transcription factors is 
implicated in a wide variety of different biological processes ranging from 
proliferation to differentiation and apoptosis (Dang et al, Int J Biochem Cell 
Biol 2000). They belong to the family of zinc-finger containing transcription 
factors which are containing three highly conserved C-terminal C2H2 zinc 
fingers which bind DNA and recognize very similar “GT-box” or “CACCC 
element” consensus sequences (Bieker JJ, J Biol Chem 2001) and 
phylogenetic analyses show their close relation to Sp1 and Krox zinc finger 
proteins. The structural component of this protein family is a single zinc atom 
which is tetrahedrally coordinated by amino acids, such as cysteine and 
histidine. This zinc holds together two β-pleaded sheets in the amino terminal 
half and an α-helix in the carboxyl terminal half of each finger (Figure 8). A 
seven-amino acid spacer TGEKP(Y/F)X also called Kruppel-link connects the 
fingers and is highly conserved between the family members (Dang et al, Int J 
Biochem Cell Biol 2000) 
 
 
 
Figure 8: Schematic representation of the zinc fingers from the KLF 
molecule.  
The three C-terminal zinc fingers including zinc ions which are able to bind target 
DNA. At the N-terminus an activation/repression domain is found (taken from 
Pearson et al, Int J Biochem Cell Biol 2008). 
 
Till now 17 members have been identified which are referred to as KLF1-
KLF17 (Suske et al, Genomics 2005) and which show either a tissue 
restricted or widely expression pattern. In the regulation of the same cellular 
process more than one KLF protein can be involved and various KLFs may 
result in opposing effects. It is also shown that KLF expression seems to be 
altered upon various cytokines. 
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KLF1 (EKLF) expression is restricted to erythroid cells where it activates β-
globin transcription and consequently plays an essential role in erythropoiesis 
(Dang et al, Int J Biochem Cell Biol 2000). KLF1 null mice die at E14.5 
because fatal anemia occurs when the switch from fetal to adult globin 
expression takes place (Perkins et al, Nature 1995). 
KLF2 (LKLF) is highly expressed in the lung but can also be found in 
erythroid, lymphoid and other tissues (Dang et al, Int J Biochem Cell Biol 
2000). KLF2 null mice show an embryonic lethality due to defective regulation 
of cardiac output and heart failure although lung development seems to be 
unaffected (Wani et al, Transgenic Res 1998). Loss of KLF2 also leads to a 
massive down-regulation of the peripheral T-cell pool suggesting that KLF2 
might play a role in the survival of these cells (Carlson et al, Nature 2006). 
KLF3 (BKLF) seems to play a role in controlling adipogenesis because KLF3 
knockout mice show less white adipose tissue and even in their fat pads are 
smaller and fewer cells (Sue et al, Mol Cell Biol 2008). 
KLF4 (GKLF) is highly expressed in post-mitotic cells of the gut and skin 
epithelium (Dang et al, Int J Biochem Cell Biol 2000). KLF4 knockout mice die 
shortly after birth due to a loss of normal skin barrier function because the late 
stage differentiation in the epidermis is abnormal (Segre et al, Nat Genet 
1999). The absence of KLF4 also leads to an impaired formation of the goblet 
cells (Katz et al, Development 2002). It should also be mentioned that KLF4 is 
expressed in embryonic stem (ES) cells and is one of four factors which are 
able to reprogram somatic cells and therefore induce pluripotent stem cells 
(iPS) in mouse as well as in human (Takahashi et al, Cell 2006; Loh et al, 
Blood 2009). 
KLF5 (IKLF/Bteb2) expression seems to be complementary to KLF4 
expression. KFF5 knockout mice die before E8.5 and heterozygote mice 
reveal defects in angiogenesis (Shindo et al, Nat Med 2002) as well as 
affected gut differentiation. It is also shown that KLF5 plays a role in the 
differentiation of white adipose tissue and thereby PPARγ appeared to be a 
target gene of KLF5 (Oishi et al, Cell Metab 2005). 
KLF6 (BCD1) is widely expressed in several embryo tissues and knockout of 
the KLF6 gene leads to embryonic death at E12.5 because of failure of yolk 
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sac vascularisation and malfunction of erythropoiesis (Matsumoto et al, Blood 
2006). 
KLF7 (UKLF) high level expression is restricted to neuronal tissue reflecting 
its importance for neuronal differentiation. KLF7 knockout mice die after birth 
because of defects in the development of axonal pathways which leads to 
widespread neurological defects (Laub et al, Mol Cell Biol 2005). The loss of 
KLF7 also leads to an increased apoptosis rate of sensory neurons. 
KLF8 (BKLF3) is important in the epithelial to mesenchymal transition (Wang 
et al, Cancer Res 2007 and J Biol Chem 2008) and plays a role in oncogenic 
transformation (Wei et al, Biol Chem 2006). It is important in the regulation of 
cell cycle progression and over expressed in several cancers (Wang et al, 
Oncogene 2007). 
KLF9 (Bteb1) shows a high level expression in the cerebellum and 
hippocampus (Morita et al, Mol Cell Biol 2003) and KLF9 knockout mice show 
mild defects in behavior, have a normal lifespan however a reduced fertility is 
proven in females du to the fact that normal uterine development and embryo 
implantation fails (Simmen et al, J Biol Chem 2004). 
KLF10 (Tieg1) knockout mice show defects in the development of bones and 
older mice develop cardiac hypertrophy. They have high osteoblast numbers 
with impaired ability to differentiate and mineralize and their bones are 
weakened and display reduced osteocyte number, density and size and thus 
leading to impaired skeletal development (Subramaniam et al, Mol Cell Biol 
2005). 
KLF11 (FKLF/Tieg2) knockout mice are phenotypically normal (Song et al, 
Blood Cells Mol. Dis. 2005) and show no effects in erythropoiesis although it 
is demonstrated that KLF11 is expressed in erythroid cells regulating 
embryonic globin expression in vitro (Emery et al, J Cell Biochem. 2007). 
KLF12 (AP-2rep) seems to be an important gene in maturation process of the 
collecting ducts after birth (Suda et al, Biochem Biophys Res Commun 2006) 
and is able to repress the expression of the activating enhancer-binding 
protein 2 α (AP-2α; Imhof et al, Mol Cell Biol 1999). 
KLF13 (FKLF2/Bteb3) knockout mice reveal a down-regulation of RANTES 
(CCL5) expression which is an important chemokine involved in the activated 
T cell response (Zhou et al, J Immunol 2007) and because of the decreased T 
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cell apoptosis these mice show enlarged thymus and spleen. In Xenopus 
KLF13 interacts with GATA-4 and therefore seems to be required for heart 
development (Lavallée et al, EMBO J 2006). 
KLF14 (Bteb5) is shown to repress the promoter of transforming growth 
factor-beta receptor II (TGF-βRII; Truty et al, J Biol Chem 2009). 
KLF15 (KKLF) is widely expressed and shows strongest expression in kidney 
and liver (Gray et al., J Biol Chem 2002). KLF15 knock out mice are viable 
and fertile but are susceptible for cardiac hypertrophy because of abnormal 
heart morphology (Fisch et al, Proc Natl Acad Sci USA 2007). If these KLF15 
knockout mice are fasted over night (18h) they exhibit severe hypoglycaemia 
(Gray et al, Cell Metab 2007). It is also shown that KLF15 regulates the 
expression of genes involved in adipocyte differentiation and glucose uptake 
(Gray et al., J Biol Chem 2002; Mori et al., J Biol Chem 2005). 
KLF16 (DRRF/Bteb4) highest expression is found in the brain and seems to 
be important for the modulation of dopaminergic transmission in the brain 
(Hwang et al, Proc Natl Acad Sci USA 2001). 
KLF17 is not well examined until now except its relation to the KLF family 
(van Vliet et al, Genomics 2006). 
The different effects of the various KLF knockouts are indicated in Table 2. 
 
Table 2: Different KLF4 transcription factors and there knockout outcome if available: 
 
outcome of the knockout 
 
 
Transcription 
factor 
 
Knockout 
existent 
embryo lethality die after birth Viable 
KLF1 √ √   
KLF2 √ √   
KLF3 √ No No √ 
KLF4 √ No √  
KLF5 √ √   
KLF6 √ √   
KLF7 √ No √  
KLF8 NO  
KLF9 √ No No √ 
KLF10 √ No No √ 
KLF11 √ No No √ 
KLF12 NO  
KLF13 √ No No √ 
KLF14 NO  
KLF15 √ No No √ 
KLF16 NO 
KLF17 NO  
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1.3.1)  KLF4 and its Importance in Various Different Physiologic 
Processes  
 
As mentioned before KLF4 is a transcription factor which is highly expressed 
in differentiated, post-mitotic epithelial cells of the skin and gastrointestinal 
tract (Garrett-Sinha et al, J Biol Chem 1996) and KLF4 knockout mice 
indicate that it may function as a proliferation-differentiation switch because 
these mice show defects in skin differentiation (Segre et al, Nat Genet 1999) 
as well as less secretory goblet cells in the colon (Katz et al, Development 
2002).  
 
It has been shown that KLF4 is inhibited by TGF-β1 which is an absolutely 
necessary cytokine for LC development (see chapter 1.1.2) and that KLF4 
seems to be critical for the development of Mo (Feinberg et al, J Biol Chem 
2005 and EMBO J 2007). Certain cytokines like IFN-γ, LPS or TNFα are able 
to induce KLF4 expression and after LPS activation of Mac KLF4 up-
regulates the expression of IL-10 by binding to its promoter (Liu et al, 
Biochem Biophys Res Commun 2007). In Mac KLF4 appears to be critical in 
mediating profinflammatory responses because after LPS or IFN-γ stimulation 
it interacts with p65 (RelA) and therefore activates Mac by induction of the 
iNOS promoter. On the other hand KLF4 itself is able to interfere with the 
TGF-β1-pathway; it can inhibit the Smad3 signalling by capturing the p300 
away from the Smad3 in certain cases. Therefore target genes of Smad3, like 
Plasminogen-Activator-Inhibitor-1-protein (PAI-1), are repressed by KLF4. 
Smad3 is known to play a critical role in suppressing important Mac markers 
of inflammation [iNOS, monocyte chemoattractant protein-1 (MCP-1); Werner 
et al, J Biol Chem 2000; Feinberg et al, Circ Res 2004; J Biol Chem 2005 and 
EMBO J 2007] whereas KLF4 is an activator of them. Interestingly Notch 
signalling seems to repress KLF4 expression (Ghaleb et al, Mol Cancer Res 
2008). As discussed before the Notch ligand Delta-1 plus TGF-β1, both are 
inhibitors of KLF4, are important factors to obtain moLC (1.2.3). KLF4 down-
regulation seems to be an important part of this differentiation process which 
is performed by cytokines and products important for LC development. 
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Depending on the cellular context, KLF4 can act either as an activator or a 
repressor. It is revealed that β-catenin signalling is inhibited by interaction 
with KLF4 which therefore leads to reduced tumorigenic activity (Zhang et al, 
Mol Cell Biol 2006). β-catenin is encoded by an oncogene and is a 
component of the wnt-pathway which activates cell proliferation. Because of 
the high expression in terminally differentiated cells a link to growth arrest is 
suggested and it is proven that KLF4 activates genes encoding negative 
regulators of the cell cycle whereas genes promoting the cell cycle are 
repressed by KLF4 (Chen et al, J Mol Biol 2003). It is also indicated that 
KLF4 is able to recruit p53 to the p21Cip1/Waf1 promoter which thus drives its 
transcription and causes cell cycle arrest (Yoon et al, J Biol Chem 2004). 
Important to notice is that KLF4 is also implicated in regulating apoptosis by 
inhibiting the transactivation of the proapoptotic protein Bax after DNA 
damage due to p53. Therefore it is able to prevent apoptosis by inhibiting the 
expression of Bax as well as by the up-regulation of p21 (Ghaleb et al, 
Oncogene 2007). 
 
Because of all these data it is logical to suggest that KLF4 might function as a 
tumor suppressor. Many studies reveal a loss of KLF4 expression in human 
tumors like colorectal, stomach, esophageal and bladder cancer (McConnell 
et al, Bioessays 2007) and over expression of KLF4 in the colon cancer cell 
line RKO leads to a reduction of colony formation and cell migration (Dang et 
al, Oncogene 2003). But there also exist studies which reveal KLF4 as a 
putative oncogene rather than a tumor suppresser: elevated levels of KLF4 
are found in many mammary carcinomas (Foster et al, Cancer Res 2000) and 
it is also over expressed in squamous-cell carcinomas of the oropharynx 
(Foster et al, Cell Growth Differ 1999). Taken together KLF4 reveals cell-
cycle-checkpoint functions after DNA damage which contributes to its activity 
as a tumor suppressor but on the other hand it also exhibits anti-apoptotic 
activity which under certain circumstances can drive cellular transformation. A 
short overview is given in Figure 9. 
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Figure 9: KLF4 and its contribution to different physiological processes.  
KLF4 is activated by different cytokines like IFN-γ, LPS or TNFα whereas TGF-β1 
and Notch signalling represses it. KLF4 itself negatively regulates the TGF-β1 
pathway by capturing away the p300 from Smad3. It is also able to interact with p65 
(RelA) and therefore mediating profinflammatory responses like activating iNOS 
(Feinberg et al, EMBO J 2007; Ghaleb et al, Mol Cancer Res 2008) 
 
 
1.3.2)  Mouse Inflammatory Monocytes show a Dependency on 
KLF4 
 
It has been postulated that KLF4 is an important downstream target of PU.1 
which is necessary to drive Mo instead of Gr development in human as well 
as in mice. Moreover, KLF4 is a direct transcriptional regulator of the human 
monocytic marker CD14 (Feinberg et al, EMBO J 2007; Alder et al, J Immunol 
2008).   
 
Mouse Mo are distinguished into “inflammatory” (Ly6Chigh) and “resident” 
(Ly6C-) Mo whereas the “inflammatory” Mo are short lived and migrate to 
inflammation sites and the “resident” Mo persist longer and seem to be 
precursors for DC and Mac (Suderkotter et al, J Immunol 2004). Alder et al. 
showed that “resident” Mo are decreased whereas “inflammatory” Mo are 
absolutely absent when KLF4 is missing thus demonstrating an important role 
of KLF4 for the production or survival of the monocytic precursor cells in the 
bone marrow. KLF4-/- cells are twice as apoptotic as KLF4+/+ cells and 
induction of KLF4 leads to higher survival rate. Because of these data and the 
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rapid down-regulation of Ly6C KLF4 seems to be an important factor for the 
differentiation, development and/or survival of inflammatory Mo (Alder et al, J 
Immunol 2008). Suderkotter et al. supposed that first “inflammatory” Mo arise 
and that “resident” Mo develop out of them (Suderkotter et al, J Immunol 
2004). The new findings from Alder et al. reveal the possibility of a common 
precursor which gives rise to either “resident” or “inflammatory” Mo whereas 
KLF4 seems to play an important role in the differentiation process and/or 
survival of “inflammatory” Mo (Figure 10). 
 
 
 
Figure 10: Myeloid development pathway of “resident” and 
“inflammatory” Mo in mouse.  
Before it was thought that first “inflammatory” Mo arise which then become 
precursors for “resident” Mo (Suderkotter et al, J Immunol 2004). New studies reveal 
a common precursor for both under the importance of KLF4. When KLF4 is absent 
no “inflammatory” Mo develop and the number of “resident” Mo is decreased which is 
consistent with the existence of a common precursor (Alder et al, J Immunol. 2008). 
 
 
1.3.3)  KLF4 and its Implication in Cell Fate Decision  
 
As mentioned before KLF4 is an important downstream target of PU.1 which 
therefore is important for Mo development (Feinberg et al, EMBO J 2007). 
Other factors which repress the differentiation into Mo or favour another cell 
type (TGF-β1 or Delta-1) are inhibitors of KLF4 expression (Ghaleb et al, Mol 
Cancer Res 2008; Feinberg et al, J Biol Chem 2005). There seems to be an 
important transcription factor network in myeloid progenitors which includes 
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the expression or inhibition of KLF4 to determine cell fate and decision. 
Another interesting finding is that KLF4 plays a necessary role in the 
differentiation process of mouse “inflammatory” Mo which are thought to be 
direct precursors for moLC in inflamed skin (Alder et al, J Immunol 2008; 
Ginhoux et al, Nat Immunol 2006). On the one hand KLF4 seems to be an 
absolutely necessary factor for LC precursors but on the other hand KLF4 
down-regulation is definitely required to obtain a moLC phenotype (Figure 
11). 
 
 
  
Figure 11: KLF4 is necessary for the moLC precursors but its down-
regulation is required to obtain LC characteristics.  
PU.1 is an important factor for Mo and it activates KLF4 expression which is 
necessary for the differentiation and survival of inflammatory Mo which are direct 
precursors of LC (Feinberg et al, EMBO J 2007; Alder et al, J Immunol 2008; 
Ginhoux et al, Nat Immunol 2006). To gain a LC phenotype it seems to be absolutely 
essential to inhibit KLF4 expression. This acts via diverse cytokines and signalling 
pathways which are important for LC differentiation. 
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2) Material and Methods  
 
2.1) Self-made Buffers and Solutions 
 
CellGroDC + Pen/Strep + Glutamax (P/S/GMX) 
CellGroDC medium (BioWhittaker) + GlutaMAX (2.5mM; Gibco/ 
Invitrogen) + penicillin/streptomycin (125U/mL each; Sigma)  
X-vivo + Pen/Strep + Glutamax (P/S/GMX) 
X-vivo15 medium (BioWhittaker) + GlutaMAX (2.5mM; Gibco/ 
Invitrogen) + penicillin/streptomycin (125U/mL each; Sigma)  
DMEM + 10%FCS + Pen/Strep + Glutamine (P/S/G) 
DMEM (Sigma) + 10% Foetal Bovine Serum (Gibco) + L-Glutamin 
(2mM; Sigma) + penicillin/streptomycin (125U/mL each; Sigma)  
RPMI + 10%FCS + Pen/Strep + Glutamine (P/S/G) 
RPMI (Sigma) 10 %Foetal Bovine Serum (Gibco) + L-Glutamin (2mM; 
Sigma) + penicillin/streptomycin (125U/mL each; Sigma)  
dH2O 
Aqua bidest. “Fresenius” (Fresenius Kabi) 
2xHBS  
8g NaCl; 6.5g HEPES; 105mg Na2HPO4 in 500ml dH2O (pH 7.0) 
RetroNectin  
90μl RetroNectin (1mg/ml; Takara Bio) in 3ml 1xPBS 
Beriglobin  
Beriglobin (CSL Behring) diluted 1:8 in PBS/BSA/Azid 
4xSampleBuffer  
0.5M Tris/HCl (pH 6.8); 40% glycerol (Roth); 4% SDS (Roth); 5μl/ml 
Bromphenolblue (Roth); 5% Mercartoethanol (Sigma) 
2xSamleBuffer  
0.5ml 4xSample Buffer; 0.5ml dH2O 
Separating gel (10%)  
2667μl 30% Acrylamid/Bis (29:1) (BioRad); 2000μl Tris/HCl pH 8.8; 
3203μl H2O; 40μl 20% SDS (Roth); 80μl 10% APS (Roth); 10μl 
TEMED (BioRad) 
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Stacking gel (4%)  
396μl 30% Acrylamid/Bis (29:1) (BioRad); 378μl Tris/HCl pH 6.8; 
2196μl H2O; 15μl 20% SDS (Roth); 20μl 10% APS (Roth); 5μl TEMED 
(BioRad) 
10x SDS-PAGE runnig buffer 
30.2g Tris (Roth); 144g Glycin (Roth); 10g SDS (Roth) in 1000ml dH2O 
10x Blotting buffer  
30,3g Tris (Roth); 144g Glycin in 1000ml dH2O 
10x PBS  
400g NaCl (Roth); 10g KCl (Roth); 72g Na2HPO4 (Roth); 10g KH2PO4 
(Roth); adjust to pH 7.4; in 5000ml dH2O 
1x PBS/Tween  
1xPBS/ 0.05% Tween (Tween20; Roth) 
1x PBS/BSA/Azid  
1xPBS; 20% BSA (Roth); 0.4% Na3N (Roth) 
50xTAE Buffer  
242g Tris/HCl; 57.1ml acetic acid; 37.2g Na2EDTA.2H2O in 1000ml 
dH2O 
5X KCM Buffer  
0.5M KCl; 0.15M CaCl2; 0.25M MgCl2 in dH2O 
SOC-medium  
2g tryptone (Roth); 0.5g yeast extract; 1ml 1M NaCl (Roth); 0.25ml 1M 
KCl (Roth); 1ml 2M Mg2+ (Roth); 1ml 2M glucose (Roth) in 100ml dH2O 
LBAmp medium  
LB medium (10g tryptone (Roth); 5g yeast extract (Roth); 5g NaCl 
(Roth); 100μg/ml Ampicillin (Applichem) 
LBAmp plates  
15g agar (Roth) in 1000ml LBAmp medium 
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2.2) Cell Culture  
 
2.2.1) Reagents and Cytokines 
 
All reagents were purchased from Sigma, Fermentas, Qiagen, Promega or 
Roth if not stated explicitly. Foetal calf serum (FCS) was supplied by Gibco 
and heat inactivated (30min at 65°C) prior to use. 
Interleukin-4 (IL-4), Interleukin-6 (IL-6), human stem cell factor (SCF), 
thrombopoietin (TPO) and tumor necrosis factor alpha (TNFα) were 
purchased from PeproTech (London, United Kingdom); transforming growth 
factor beta-1 (TGF-β1) was purchased from R&D Systems (Wiesbaden, 
Germany); Interleukin-15 (IL-15), fms-related tyrosine kinase 3 ligand (FL, 
Flt3L), granulocyte colony-stimulating factor (G-CSF) and macrophage 
colony-stimulating factor (M-CSF) were obtained from PeproTech (London, 
United Kingdom); granulocyte-macrophage colony-stimulating factor (GM-
CSF) was kindly provided by Novartis Research Institute (Vienna, Austria); 
donkey α-human Immunoglobulin G (dkαH-IgG) was obtained from Jackson 
ImmunoResearch and Delta-1 IgG was a gift from Bernstein ID.  
 
2.2.2) Cell Lines and Culture 
 
U937Te cells were maintained in RPMI plus 10% FCS plus Penicillin 
(10.000U/ml)/ Streptomycin (10mg/ml)/L-Glutamin (200mM) medium (P/S/G) 
in cell culture flasks (Nunclon™Δ Surface, Nunc). Phoenix cell lines (Ph-GP 
and Ph-E) were grown in DMEM plus 10% FCS plus P/S/G on cell culture 
dishes (Nunclon™Δ Surface, Nunc) and were detached by Trypsin-EDTA 
(Sigma). All cell lines and primary cells were maintained at 37°C in the 5% 
CO2 incubator. 
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  2.2.2.1) Passaging of Cells 
 
First the medium was removed from the cell monolayer and than the cells 
were trypsinised using 3ml Trypsin EDTA. When the cells started to detach 
from the plate 8ml medium were added, to stop Trypsin EDTA function. The 
cell suspension was then split (for example 1:5) to a new culture tissue plate 
containing 10ml of the needed medium and incubated at 37°C. 
 
  2.2.2.2) Freezing and Unfreezing of Cells 
 
After trypsinising the cells were pelleted by centrifugation and washed once 
with PBS. Afterwards the pellet was taken up in 1ml freezing medium (10% 
Dimethyl Sulfoxide (DMSO), 70% DMEM, 20% FCS) and transferred to a 
freezing tube. The cells got slowly frozen, first an ice then at -20°C; storage of 
the cells was carried out at -80°C. 
For unfreezing, cells from the freezing tube were thawed on ice first, then at 
room temperature, resuspended in 8ml of prewarmed medium and pelleted. 
Following a washing step with PBS to remove the DMSO, the cell pellet was 
then resuspended in growth medium, transferred into a plate and incubated at 
37°C. 
 
2.2.3)  Isolation of Cord Blood CD34+ and CD14+ Cells 
 
Cord blood samples from healthy donors were collected during healthy full-
term deliveries. Approval was obtained from the Medical University of Vienna 
institutional review board for these studies. Informed consent was provided 
according to the Declaration of Helsinki. Cord blood mononuclear cells 
(MNCs) were obtained by density gradient centrifugation over Lymphoprep 
(Axis-Shield PoC AS, Oslo, Norway). CD34+ cells were isolated from 
mononuclear cord blood cells using MACS Direct CD34 Progenitor Cell 
Isolation Kit (Miltenyi Biotech, Bergisch Gladbach, Germany) according to the 
instructions of the manufacturer. The purity of the isolated CD34+ cells 
analyzed by flow cytometry was greater than 95%. CD14+ cells were isolated 
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from mononuclear cord blood cells or mononuclear peripheral blood cells by 
using a CD14-PE antibody (Caltag) which is recognized by anti-PE 
microbeads (Miltenyi Biotec). The cells were collected by using MACS 
columns (Miltenyi Biotec). 
 
2.2.4)  Retroviral Vectors, Gene Transduction and Infection  
 
For the ectopic expression study a RV-GFP plasmid (empty or including 
KLF4) which contains the FACS detectable marker GFP from Mukesh K. Jain 
was obtained.  
The packaging cell lines Phoenix E (Ph-E; ecotropic retrovirus) and Phoenix-
Gag-Pol (Ph-GP; amphotropic virus) were transfected by calcium phosphate 
precipitation according to the Nolan lab protocol for retroviral transfection 
(http://www.stanford.edu/group/nolan/); the Ph-GP were cotransfected with 
the gibbon ape leukemia virus envelope protein (GalV). For the transfection 5 
to 10µg of DNA were used and mixed with 61µl 2M CaCl2, 425µl dH2O 
(Fresenius) and 500µl 2xHBS by vortexing 10 to 15 seconds, during an 
incubation time of 10 to 15min, 3µl 50mM Chloroquin (Sigma) was added to 
the Ph-GP or Ph-E plates. DNA precipitate was added drop wise onto the 
cells. After 6 to 12 hours the medium was changed and the cells were 
incubated for >36 hours. The virus supernatant was collected with a syringe 
and filtered through a 0.45µ filter (IWAKI). 
Target cells (2x104 to 5x105) were plated on RetroNectin (Takara Bio, Shiga, 
Japan)-coated nontissue suspension culture plates (o/n 4°C) coated with 
virus (4 to 6 hours before) in specific growth medium. Infection was repeated 
2 to 3 times in an interval of 12 to 24 hours. CD34+ cells were infected in 
expansion mix (SCF, FL, TPO; each 50ng/ml). 
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2.2.5) Lineage Differentiation  
 
All are 100x mixes and from these always 10µl were used to be given in 1ml. 
All cells were expanded in serum free X-VIVO 15 medium +P/S/GMX plus 
expansion mix (50ng/ml TPO, 50ng/ml Flt3L and 50ng/ml SCF) for three days 
before cultivation. 
To generate LC GM-CSF (200ng/ml), Flt3L (50ng/ml), SCF (20ng/ml), TNFα 
(2.5ng/ml), and TGF-β1 (1ng/ml) were used in serum-free Cell Grow DC 
supplemented with P/S/GMX. They were differentiated for 7 days; after day 4 
the medium was changed. For the generation of intDC the same as for LC 
generation was used however without TGF-β1 but plus 10% FCS. On day 4 
the medium was changed into intDC-mix 2 containing GM-CSF (200ng/ml) 
and IL-4 in RPMI +10% FCS and +P/S/G. The cells were harvested on day 9 
or 10. For Mo differentiation M-CSF (100ng/ml), Flt3L (50ng/ml), SCF 
(20ng/ml) and IL-6 (20ng/ml) were used in serum-free X-VIVO 15 
supplemented with P/S/GMX. After day 4 the medium got changed every 2 or 
3 days and the cells were harvested on day 10. To get granulocytes G-CSF 
(100ng/ml) and SCF (20ng/ml) were used in serum-free X-VIVO 15 medium 
+P/S/GMX. Also here the medium got changed every 2 or 3 days after day 4 
and the cells were harvested on day 13 or 14. 
There is another differentiation method using serum-containing media. 
Therefore the cells were cultivated in CellGroDC supplemented with P/S/GMX 
and 10% FCS for 5 days in GM-CSF (200ng/ml), TNFα (2.5ng/ml), Flt3L 
(50ng/ml) and SCF (50ng/ml). After the five days the cells were grown in 
RPMI + 10%FCS with either GM-CSF plus TGF-β1 (1ng/ml) and TNFα to 
obtain LC, or in GM-CSF plus IL-4 (25ng/ml) and TNFα to acquire DC, or in 
M-CSF (100ng/ml), Flt3L (50ng/ml), SCF (20ng/ml) and IL-6 (20ng/ml) to gain 
a monocyte phenotype. 
 
 2.2.6) CD14 Generation and Delta-1 Coating 
 
CD14+ cells were cultivated in RPMI + 10% FCS until day seven. To obtain 
moLC CD14+ cells were cultivated on Delta-1 coated nontissue suspension 
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culture plates. Therefore, the plates were coated with 10µg/ml dkαH-IgG in 
PBS which were incubated for one hour at 37°C, after that blocked for 45min 
at RT with RPMI + 10% FCS followed by an addition of 10µg/ml Delta-1 either 
o/n at 4°C or for three hours at 37°C. To those Delta-1 coated plates GM-CSF 
(200ng/ml) and TGF-β1 (10ng/ml) were added. For moDC cells got cultivated 
in GM-CSF and IL-4 (25ng/ml), or GM-CSF, TGF-β1 and IL-4. Also a possible 
moDC generation method is in GM-CSF with either TNFα (10ng/ml) or IFNα 
(400U/ml) or IL-15 (200ng/ml). To obtain monocytic cells they were left in GM-
CSF. 
 
2.3) Bacteria 
 
2.3.1) Cultivation of Bacteria 
 
Bacteria were cultivated in sterile Luria-Bertani (LB) media at 37°C. For 
bacteria harbouring a plasmid selective media which was supplemented with 
a specific antibiotic was used. For freshly transformed bacteria a SOC media 
was used. This media contains 5g Bacto-yeast extract , 20g Bacto-tryptone , 
0.5g NaCl , 2.5ml 1M KCl , ddH2O  to final volume of 1l , pH adjusted to 7.0 
using 10M NaOH, autoclaved and sterilized and after that 20ml of sterile 1M 
glucose was added before use. For storage bacterial overnight cultures were 
mixed with glycerol (30% glycerol) and stored at -80°C. For recultivation a 
little bit of the stock was inoculated in 3ml LB media (+/- selective antibiotics) 
at 37°C over night with shaking. 
 
 2.3.2) Bacterial Transformation 
 
Therefore KCM competent cells were used. They were made by inoculating 
the cells in LB media until the OD600 is between 0.3-0.6, they were pellet at 
2500g for 10min at  4°C, resuspended in 10ml TSB and incubated on ice for 
10min. Aliquots were snap freeze in liquid N2 and stored at -80°C. The TSB 
buffer contained 1x LB broth, 10% PEG (MW 3.350), 5% DMSO, 10mM 
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MgCl2, 10mM MgSO4 and was filled up with ddH2O to 50ml. LB broth was 
autoclaved before the other ingredients were added, after that the solution got 
sterile filtered and was stored at 4°C. 
For the transformation the KCM cells were thaw on ice for 10min. Meanwhile 
20µl 5x KCM buffer and 10-20µl Ligation product (2.4.3) or the plasmid of 
interest were mixed and filled up with ddH2O to 100µl. 100µl KCM cells were 
added, left on ice for 20min, then for 10min on room temperature, 900µl SOC 
medium was added and the cells were incubated at 37°C for 60min with 
shaking. 100-300µl of the cell suspension were transferred on LB plates (+ 
antibiotics) and placed at 37°C over night. After that positive clones were 
picked and cultivated over night to isolate the DNA which was controlled by a 
control restriction if the insert is inside or the right plasmid was taken up. 
 
2.3.3) Isolation of Bacterial Plasmid DNA  
 
For the purification of high amounts of the plasmid DNA the QIAfilter Plasmid 
Maxi Kit (QIAGEN) was used. A single colony got inoculated in 2 to 3ml LB 
media containing antibiotics (AB) at 37°C shaking over night to grow a starter 
culture. 300µl of this culture was transferred into fresh 150ml LB media plus 
AB to generate an overnight culture (37°C/shaking over night). The bacterial 
cells were harvested by centrifugation (5000g/15min/4°C). The plasmid DNA 
purification was performed according to the protocol. The bacterial pellet was 
resuspended in 4ml P1 Buffer, 4ml P2 Buffer were added and mixed by 
inverting followed by an incubation period of 5min at RT. After addition of P3 
Buffer (4ml) the suspension got mixed and the lysate was applied into the 
QIAfilter Cartridge. During the subsequent incubation period (10min at RT) 
the precipitate floated and formed a layer at the top of the solution to enable a 
successful filtration. In the meantime a QIAGEN-tip 500 column was 
equilibrated by applying 10ml QBT Buffer. The cell lysate was filtered trough 
the QIAfilter Cartridge into the equilibrated QUIAGEN-tip and entered the 
column by gravity flow. The column was washed twice with 30ml QC Buffer 
and the plasmid DNA was eluted in 15ml QF buffer. To precipitate the DNA 
10.5ml isopropanol were added followed by centrifugation (1h/5000g at 4°C). 
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The DNA pellet was washed with 5ml 70% EtOH and centrifuged (1h/5000g 
at 4°C). The pellet was air dried and dissolved in 200μl dH20. To determine 
the yield, DNA concentration was determined by spectrophotometry at 
260nm. 
 
2.4) DNA, RNA and proteins 
 
2.4.1)  Restriction Enzyme Digest and Gel Electrophoresis 
 
Enzymes were obtained from Fermentas. For every enzyme there is a 
specific restriction buffer, for double digest 1x or 2x Tango buffer was used. 
The reaction mixture for the digest contains 0.5-7µg DNA, 10x or 20x reaction 
buffer, 1-5µl enzyme, filled up with dH2O to 20 or 100µl and placed at 37°C 
for 2-3h. 
The digested DNA was loaded onto a 1% agarose gel [1 g agarose (Seakem 
LE Agarose; Biozyme) was dissolved in 100 ml 1x TAE (Tris-Acetate-EDTA) 
Buffer by boiling this mixture in a microwave and after cooling down to ~50°C 
10 μl Ethidium Bromide (Roth) were added]. To the samples 6x Loading Dye 
(Fermentas) was added before loading onto the gel. The gel was run using 
the Bio-Rad Sub-Cell GT system (Bio-Rad) in 1xTAE and the bands got 
visualized using the Lumi-ImagerTM.  
 
2.4.2)  DNA Extraction/Purification from Agarose Gel 
 
The bands of interest can be cut out of the agarose gel and the DNA can be 
extracted by using the QIAquick Gel Extraction Kit protocol. According to the 
protocol 3x volume of QG buffer was added to 1x volume of the excised gel 
fragment and dissolved at 50°C for 10 min following the addition of 1x volume 
of isopropanol (Roth). To bind DNA, the sample was applied on the QIAquick 
column and centrifuged 1 min at 13000 rpm. To remove trace amounts of 
agarose the column was washed with 0.5 ml of QG buffer (1 min/13000 rpm). 
Additional washing was performed using 0.75 ml PE Buffer (prior to 
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centrifugation the column membrane was incubated with the applied PE 
buffer for 5 min at RT). To remove residual fluid the column was centrifuged 
for 1 min at 13000 rpm followed by elution. Therefore 30μl dH2O were added 
to the centre of the membrane, incubated for 1 min, and then centrifuged (1 
min/13000 rpm). So the clean DNA was eluted and can be used for further 
experiments. The concentration of the DNA content was determined by gel 
electrophoresis using a molecular weight marker (DNA ladder mix from 
Fermentas). The intensity of the band was compared with the marker which 
had a know concentration. 
 
 2.4.3) Ligation 
 
After the determination of the DNA content of the vector and the insert a 
vector:insert ratio of 1:1 to 1:3 is used for ligation or it is determined 
mathematically by following formula: 
 
ng vector x kb size insert 
           x 3:1 = ng of insert 
        kb size vector 
 
 
The reaction mixture contained 50-400ng of the linear vector DNA, the 
mathematically determined amount or a 1:1 to 1:3 ratio of the insert DNA, 2µl 
of 10x Ligation Buffer and 0.4µl T4 DNA Ligase. This mixture was filled up to 
20µl with dH2O and was put on 16°C over night. As a control the same 
mixture without the T4 DNA Ligase was used. 10µl of the ligation product 
were used for the following transformation of bacteria (2.3.2). 
 
 
2.4.4) RNA Isolation, cDNA and qRT-PCR 
 
For RNA isolation 1x105 cells were harvested, washed twice with 1xPBS and 
resuspended in 70µl RLT Buffer (Qiagen; RNeasy® Micro Kit) with 1/100 β-
Mercaptoethanol by vortexing for 30 seconds. RNA isolation was done 
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according to the manufacturer’s protocol (Qiagen; RNeasy® Micro Kit). After 
addition of 350μl of 70% EtOH to the sample it was transferred to the RNeasy 
column and centrifuged for 15sec at 8000g. The column was washed with 
350μl RW1 buffer (15sec/8000g) followed by the addition of 80μl of a DNase 
solution (10μl DNase I stock solution; 70μl RDD buffer) and incubation for 
15min at RT. The column was washed with 350μl RW1 buffer (15sec/8000g), 
500μl RPE buffer (15sec/8000g) and PE buffer (2min/8000g). To remove the 
residual fluid the column was centrifuged at full speed for 1min. For RNA 
elution, RNasefree water (15 to 20μl) was used (1min/8000g). To increase the 
RNA yield the described elution procedure was repeated twice. From the 
isolated RNA a cDNA can be generated; therefore maximal 16.25µl RNA was 
taken and mixed with 1µl 25mM oligo T20 primers (Fermentas); primer 
annealing was performed using following PCR program: 5min/70°C; 
5min/4°C. 5µl RevertAid [TM] H Minus M-MuLV RT Buffer 5x; 1.25µl dNTP 
mix; 0.5µl RiboLock RNase Inhibitor (40u/µl) and 1µl RevertAid [TM] H Minus 
M- MuLV RT (200u/µl; all these reagents are obtained from Fermentas) were 
added and a cDNA was prepared using a 2 step cycle; 42°C for 1 hour 
followed by 70°C for 15 min and cooling to 4°C. The resulting cDNA was 
stored at -20°C. For the qRT-PCR detection a LightCycler 2.0 was used. 
Reactions were carried out in LightCycler® Capillaries (20µl) obtained from 
Roche Diagnostics GmbH using 7.5µl of Sybr Green Mix and 0.75µl 10xBSA 
(Invitrogen); 0.5µl 10µM forward and reverse primers of interest and 1.5µl 
cDNA (1:5 dilution with dH2O) in an end volume of 15µl. Amplification 
parameters were denaturation at 95°C for 5min followed by 40 cycles of 95°C 
for 15sec and 60°C for 60sec. All primers were designed using the Primer3 
design tool and were obtained from MWG. For relative quantification, data 
were analyzed using the “Normalized Relative Quantification” method 
(LightCycler; Roche). Expression levels of target genes in cells were 
normalized to HPRT and shown relative to unstimulated cells (time point 0). 
2.4.5) Protein Extracts and Western Blot 
 
For Western Blot analysis 2x105 or more cells were harvested, washed twice 
with 1xPBS, resuspended in 20µl 2xSample Buffer and put on 95°C for 
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10min. The probes were frozen at -20°C until usage. Minimum 1x105 cells 
were used. 
10% separating and 4% stacking gels were prepared and ran in 1x SDS PAGE Buffer. 
Proteins resolved by sodium dodecyl sulphate-polyacrylamid gel electrophoresis 
(SDS-PAGE) were transferred to a polyvenylidene difluoride membrane (Immobilon-
P, Millipore) at 100 V for 90 min using a Bio-Rad Criterion Blotter (Bio-Rad) and 
after that these membranes were blocked with 1xPBS-Tween/5% low-fat milk for 
60min at RT. Primary antibodies GKLF (Santa Cruz Biotechnology) and anti-actin 
(Sigma-Alsrich) were diluted 1:1000 in 1xPBS-Tween/3% low-fat milk and added to 
the membrane over night at 4°C. Membranes were washed 3x with 1x PBS-Tween 
before adding the secondary antibodies which were conjugated to horse radish 
peroxidise (HPR); donkey anti-goat IgG HPR (for GKLF) or goat anti-rabbit IgG 
HPR (for actin; were used at a dilution of 1:2500 in 1xPBS-Tween/3% low-fat milk) 
for 1 to 2h at RT. Detection was performed with the chemiluminiscent substrate 
SuperSignal WestPico or WestDura (Pierce Biotechnology). Lumi-ImagerTM or the 
Fujifilm Las-4000 were used for data imaging.  
 
2.5) Fluorescence Activated Cell Sorting (FACS)  
 
For membrane staining cells were harvested and washed with 1x phosphate-
buffered saline (PBS)/ bovine serum albumin (BSA)/azid. The supernatant got 
sucked off and the cells got remained in the needed volume with 1x 
PBS/BSA/azid [50µl cells were needed for one staining, transfer them into 
micronic tubes (Thermo Scientific)]. 1/10 Beriglobin was added to block 
unspecific binding and incubated for 10min on ice. Then 10µl of the needed 
mAbs were added and incubated for 20 to 30min at 4°C. After that the cells 
got washed again with 1x PBS/BSA/azid and, if needed, the Streptavidin 
(SA)-PerCP (10µl per staining) was added and incubated again for 20 to 
30min. Next the cells were washed with 1x PBS before FACS analysis or in 
case of a intracellular staining fixed with 100μl Fixation Medium (An Der 
Grub) for 5 min at RT. Afterwards cells were washed and permeabilized by 
addition of 100 μl Permeabilization Medium (An Der Grub) followed by an 
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incubation with 10µl of the antibody against an intracellular marker for 20 to 
30min at RT. 
Murine monoclonal antibodies (mAbs) of the following specificity are used: 
phytocoerythrin (PE)-conjugated mAbs specific for Langerin, CD11b, CD14, 
CD15 (BD Biosciences) and Lactoferrin [LF; intracellular (An Der Grub)]; 
biotinylated mAb CD11b (BD Pharmingen) combined with SA-PerCP; and 
allophycyanin (APC)-conjugated anti-CD1a (BD Pharmingen) and anti-CD14 
(Caltag Laboratories or BD Biosciences). All antibodies were pre-diluted 1:5 
with 1xPBS/BSA/Azid in exception of PE-CD14 (1:10), PE-Langerin (1:10), 
APC-CD14 (1:30), LF (1:2), and SA-PerCP (1:100). 
For analysis a FACS-Calibur flow cytometer and CellQuest software were 
used (Becton Dickinson). For cell sorting the BD FACS-Aria flow cytometer 
was used. 
 
2.6) Statistical Analysis 
 
Statistical analysis was performed using the paired, 2-tailed Student t test; P 
values less than <0.05 were considered significant. 
  - 42 -  
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3) Results 
 
3.1)  Up- and Down-regulated Factors via TGF-β1 – Microarray 
Approach 
 
It has been shown that TGF-β1 is sufficient to induce LC commitment from 
CD34+ HSC in vitro. However, also in vivo TGF-β1 seems to be absolutely 
required for LC development (Strobl et al, Blood 1997). In accordance with 
this, mice lacking TGF-β1 are devoid of LC (Borkowski et al, J Exp Med 
1996). Although the importance of TGF-β1 in LC commitment was long ago 
established, the transcriptional mechanisms underlying this TGF-β1 
dependent LC development still remain elusive.  
We used a microarray approach to identify potential key molecules that act 
downstream of TGF-β1 to induce LC commitment. For this purpose 
CD34+/CD45RAhigh cells, which are highly enriched in myeloid progenitor cells 
and can most efficiently give rise to both LC in the presence of TGF-β1 and 
monocytic precursors in the absence of TGF-β1, were FACS sorted and 
cultivated in LC-mix w/o TGF-β1 for two days. In contrast, the CD45RAint cells 
are believed to possess lymphoid potential and the erythroid lineages seem to 
arise from the CD34+/CD45RAlow cells. Afterwards, cells were stimulated with 
TGF-β1 or left untreated. RNA samples were taken after 6 and 24 hours. 
These RNA samples were then hybridized on an Affymetrix chip U133plus 
2.0. (Jurkin J et al. unpublished data, Figure 12). By these means we wanted 
to identify novel transcriptional regulators that act downstream of TGF-β1 and 
might alone or in combination be sufficient to induce LC commitment. 
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Figure 12: Identification of factors which are regulated via TGF-β1 – 
experimental setup.  
A) CD34+/CD45RAhigh cells were FACS sorted and cultivated plus TGF-β1 to acquire 
LC or without TGF-β1 for a Mo/DC precursor cell B) FACS blots from day 7. With 
TGF-β1 a LC population developed with CD207 and CD1a expression, whereas 
without TGF-β1 no CD207 expression is detectable but CD14. C) CD34+/CD45RAhigh 
cells were cultivated in LC-Mix w/o TGF-β1 for two days. After that they get cultivated 
in presence or absence of TGF-β1 and RNA samples were taken after 6 and 24 
hours. These RNA samples were hybridized on an Affymetrix chip U133plus 2.0. and 
used for further analysis (Jurkin J et al. unpublished data).  
 
 
3.2)  KLF4 is one of the Strongest Down-regulated Factors in 
Response to TGF-β1 Stimulation of Myeloid Progenitor Cells 
 
In the above screen (Figure 12) we found several transcription factors to be 
significantly up- or down-regulated. We used Real Time- (RT-) PCR to 
validate several factors (Figure 13A). KLF4 was on of these factors of 
particular interest. Feinberg et al. previously showed that this factor is an 
active inducer of monopoiesis (Feinberg et al. EMBO J. 2007). In accordance 
with this, we found KLF4 specifically down-regulated by TGF-β1 during LC 
development, whereas its expression increases in the minus TGF-β1 
condition, in which monocytic-like cells are generated (Figure 13B). In line 
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with this only Mo and intDC showed KLF4 protein expression, whereas LC 
and Gr lacked substantial levels of KLF4. Interestingly, we found the 
strongest KLF4 expression in intDC and not, as expected from literature, in 
Mo (Figure 13C). 
 
 
 
 
 
Figure 13: Real time PCR analysis shows a significant down-regulation 
of KLF4 in the presence of TGF-β1.  
CD34+ cells were cultivated in LC-mix in presence or absence of TGF-β1. RNA 
samples were taken at the indicated time points after TGF-β1 addition and RT-PCR 
analysis was performed. A) Expression levels were normalized to GAPDH and shown 
as x-fold induction or reduction compared to TGF-β1 unstimulated cells. Bar 
diagrams represent the mean value ± S.D. for 4-8 independent experiments. B) KLF4 
expression levels were normalized to GAPDH and shown relative to unstimulated 
cells. ? Black bars symbolize TGF-β1 treated cells, ? white bars the TGF-β1 
untreated cells. Bar diagrams represent the mean value ± S.D. for four independent 
experiments. *p<0.05; **p<0.005, paired 2-tailed t test. C) Differentiation of CD34+ 
cells into the different lineages in serum-free media. Used cytokine mixes were 
described in material and methods. LC (CD1a+ CD207+) were cluster purified at day 
7, intDC (CD1a+ CD11b+) and Mo (CD11b+ CD14+) were FACS sorted at day 11, Gr 
(LF+ CD15+) at day 13. Cell lysates were analysed by western blot, actin served as a 
loading control. Data are representative of three independent experiments. 
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3.3)  Ectopic Expression of KLF4 Results in a Significant Down-
regulation of CD1a and Up-regulation of CD14 
 
3.3.1)  Retroviral Vectors and in vitro Differentiation Model 
 
We ectopically expressed a retroviral KLF4 GFP construct (Figure 14) in 
CD34+ cells to analyse the effect of this transcription factor on the myeloid 
lineage commitment. We were especially interested in the influence of KLF4 
on Mo/DC subset differentiation.  
 
 
 
 
 
Figure 14: The ectopic retroviral expression vector RV-GFP.  
A) Vector map of the RV-GFP control (CTRL) vector (Ranganath S and Murphy KM 
et al. J Immunol. 1998 and Mol Cell Biol. 2001) and RV-KLF4 GFP vector (Feinberg 
MW et al. J Biol Chem. 2005). B) U937Te cells were retroviral infected with 10µg RV-
KLF GFP and CTRL vector DNA. After three days GFP+ cells were FACS sorted and 
cell lysates got analysed by Western Blot. Actin served as a loading control. 
 
 
For this purpose we used a two step in vitro generation model which was 
described previously (Chapter 2.2.5). In this model CD34+ cells differentiated 
in serum-containing media with GM-CSF and TNFα into CD1a and CD14 
single positive cells. CD1a+ cells further give rise to LC whereas the CD14+ 
population develops into CD14-derived DC (moDC) under the same culture 
conditions (Figure 15; Caux et al. J. Exp. Med. 1996). 
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Figure 15: Generation model in serum-containing media.  
The cultivation of isolated CD34+ cells in presence of GM-CSF and TNFα results in 
two precursor populations: a CD1a+ and a CD14+ population (Caux et al. J. Exp. 
Med. 1996). Until day 11 to 13 the CD1a+ population differentiates under TGF-β1 
stimulation into a LC phenotype. Conversely, the CD14+ population differentiates with 
IL-4 into a DC-like phenotype. Upon M-CSF stimulation CD14+ cells differentiate into 
a macrophage-like phenotype (M-CSF Mac). 
 
 
3.3.2)  Ectopic KLF4 Promotes CD14+ and CD11b+ but Inhibits 
CD1a+ Cell Differentiation 
 
We cultivated RV-KLF4 GFP and empty control (CTRL) vector infected 
CD34+ cells with GM-CSF and TNFα until day 13 to investigate the effect of 
KLF4 in this differentiation model. GFP+ cells were gated for analysis of KLF4 
and CTRL vector transduced cells. During culture, cells were analysed by 
FACS at day 5 and day 11 to 13 for different lineage informative markers 
(Figure 3). At day 5 we observed a significant decrease of the CD1a+ cells in 
the KLF4 transduced population (Figure 16A, left panel). In addition, KLF4 
transduced cells included high CD14 marker expression and reduced CD1a 
marker expression at day 13 (Figure 16, right panel). Furthermore, this CD14 
induction and CD1a reduction went along with an increase of the CD11b 
marker which is a dendritic/monocytic marker. Therefore, ectopic KLF4 
expression in CD34+ cells seems to promote the development of CD14+ 
monocytic cells at the expense of CD1a+ dendritic cells in this culture system.  
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Figure 16: Ectopic KLF4 promotes the generation of CD14+ and CD11b+ 
cells at expense of CD1a+ cells.  
Isolated CD34+ cells were infected with RV-KLF4 GFP and CTRL vector (three 
infection rounds) followed by a stimulation with GM-CSF and TNFα in serum-
containing media until day 13. A) Expression of the different markers was determined 
by FACS analysis after day 5 and 13. Gates for the analysis were set for GFP+ cells. 
The data shown represents one of three independent experiments with comparable 
results. B and C) Statistical analysis of day 5 and 13. ? Black bars symbolize RV-
KLF4 GFP transduced cells, ? white bars the empty CTRL vector transduced cells. 
Bar diagrams represent the mean value ± S.D. for four independent experiments (B) 
or one experiment (C). *p<0.05; paired 2-tailed t test.  
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3.3.3)  KLF4 Promotes another DC-like Phenotype and Inhibits 
considerably the LC Pathway 
 
It has been shown that moDC develop from CD14+ precursor cells generated 
from CD34+ cells after 5 days of culture with GM-CSF and TNFα. This 
precursor population can be further induced to develop into moDC or LC via 
addition of GM-CSF with either IL-4 or TGF-β1, respectively. The analysis of 
KLF4 expression levels in this culture system showed increased KLF4 
expression after 5 days of culture with GM-CSF and TNFα relative to fresh 
CD34+ cells. At day 13 KLF4 expression is up-regulated in IL-4 condition 
whereas reduced under TGF-β1 condition (Figure 17C). 
 
moDC develop from CD14+/CD11b+ intermediate cells which share many 
features with blood Mo (Caux et al. Blood 1997). Furthermore, we found high 
KLF4 protein levels in intDC (Figure 13C). Therefore, we assessed the impact 
of KLF4 on the developmental pathway of the DC phenotype. CD34+ cells 
were transduced with ectopic KLF4 or CTRL vectors and differentiated into 
moDC by applying the above described culture system. We found the 
percentage of CD11b+ cells to be significantly increased in cells ectopically 
expressing KLF4. Interestingly, the CD14 marker expression remained 
constant. This increase in CD11b was furthermore accompanied by a 
significant loss of CD1a positive cells (Figure 17A). Therefore, we saw no 
inhibition of DC. This data, moreover, indicates that ectopic KLF4 expression 
promotes another DC-like phenotypes compared to the control. 
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Figure 17: KLF4 promotes moDC differentiation which shows another 
phenotype than CTRL cells.  
CD34+ cells were transduced with RV-KLF4 GFP or empty CTRL vector and then 
stimulated in serum-containing media with GM-CSF plus TNFα for five days. A) Cells 
were generated under moDC culture condition in serum-containing media until day 
13. B) Cells were generated under LC culture condition in serum-containing media 
until day 13. Gated GFP+ cells were analysed by FACS at day 5 and day 13 for the 
indicated markers. The data shown represents one of three independent experiments 
with comparable results. C) Cell lysates were analysed by western blot, actin served 
as a loading control. Data are representative of two independent experiments. 
 
 
 
We estimated an inhibition of the LC pathway with ectopic KLF4 because the 
previous experiments showed a significant inhibition of the CD1a marker 
expression (Figure 16 and 17). As expected, we detected a significant decline 
of the CD1a CD207 double positive population with ectopic KLF4 under TGF-
β1 conditions. Furthermore, we observed an increase of CD11b and CD14 
single as well as double positive cells in this population. This implicates that 
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KLF4 selectively impairs the LC-like DC phenotype, while promoting Mo and 
another DC-like phenotype compared to the control (Figure 17B). We noticed 
an increase of CD11b and an insignificant expand of monocytic cells in KLF4 
transduced cells in moDC generation culture (Figure 18, left diagram); under 
LC culture condition this monocytic enhancement was even significantly 
advanced (Figure 18, right diagram).   
 
 
 
Figure 18: Ectopic KLF4 inhibits significantly the LC generation and 
favours a dendritic/monocytic phenotype.  
CD34+ cells were transduced with RV-KLF4 GFP and empty CTRL vector and 
generated in serum-containing media for five days with GM-CSF and TNFα followed 
by subculture in moDC or LC culture conditions until day 11 to 13. Gated GFP+ cells 
were analysed by FACS at day 11 to 13 for the indicated markers. ? Black bars 
symbolize ectopic KLF4 cells, ? white bars the CTRL cells. Bar diagrams represent 
the mean value ± S.D. for four independent experiments. *p<0.05; **p<0.005, paired 
2-tailed t test. 
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3.4)  Monocyte Development in the Absence of M-CSF is Facilitated 
by KLF4  
 
 
KLF4 was found to be an active inducer of monopoiesis (Feinberg et al. 
EMBO J. 2007) by activating the CD14 as well as the M-CSFR promoter. We 
were interested in the analysis of the impact of ectopic KLF4 expression on 
cells cultivated in Mo conditions containing M-CSF.  
 
 
We obtained an up-regulation of KLF4 protein levels shortly after M-CSF 
addition (two days after). However, it seemed as if KLF4 became slightly 
down-regulated from day 7 to day 13. We suppose a dependency on KLF4 at 
the beginning of Mo development, whereas the down-regulation of KLF4 is 
essential to finish this differentiation process (Figure 19C). Therefore, we 
analysed the impact of ectopic KLF4 on MO differentiation. All marker 
expressions remained constant in the assessed ectopically KLF4 infected 
cells, except a strong reduction of CD1a marker expression (Figure 19B). 
Many cells developed into CD11b/CD14 double positive cells even with the 
empty CTRL vector (Figure 19A, upper panel). Therefore, we tried a Mo 
generation culture system without M-CSF, which is an absolutely necessary 
cytokine for Mo generation. Interestingly, KLF4 compensated the absence of 
M-CSF. In conditions without M-CSF we observed a strong induction of the 
Mo population with ectopic KLF4 compared to the empty CTRL vector (Figure 
19A, lower panel). 
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Figure 19: CD11b is enhanced by ectopic KLF4 and results in another 
DC-like phenotype.  
RV-KLF4 GFP or empty CTRL vector transduced CD34+ cells were cultivated in 
serum-containing media under Mo culture condition in serum-containing media until 
13. A) Gated GFP+ cells were analysed by FACS at day 5 and day 13 for the 
indicated markers. The data shown represents one of three independent experiments 
with comparable results for the condition containing M-CSF. B) Gated GFP+ cells 
were analysed by FACS at day 11 to 13 for the indicated markers. ? Black bars 
symbolize ectopic KLF4 cells, ? white bars the CTRL cells. Bar diagrams represent 
the mean value ± S.D. for four independent experiments. *p<0.05; paired 2-tailed t 
test. C) Cell lysates were analysed by western blot, actin serves as a loading control. 
Data are representative of two independent experiments. 
 
 
Additionally, we checked Mo development in serum-free culture conditions without 
M-CSF. In common with MO culture condition in serum-containing media, cells 
ectopically expressing KLF4 efficiently acquired the monocytic phenotype. The 
increase of monocytic markers was significant after 7 and 11 days in culture (Figure 
20B). 
 
Results 
 
 - 54 -  
 
 
Figure 20: KLF4 promotes the differentiation of Mo in the absence of M-
CSF.  
RV-KLF4 GFP and empty CTRL vector transduced CD34+ cells were cultivated with 
or w/o M-CSF under Mo culture condition in serum-free media. A) Gated GFP+ and 
GFP- cells were analysed by FACS for the indicated markers at day 11. 27% GFP+ of 
CTRL vector and 11% GFP+ of RV-KLF4 GFP transduced cells. B) FACS blots of 
gated GFP+ and GFP- cells at day 11 for the indicated markers. 34% GFP+ of CTRL 
vector and 14% GFP+ of RV-KLF4 GFP transduced cells. The data shown represents 
one of three independent experiments with comparable results. ? White bars 
symbolize empty CTRL vector, ? black bars the ectopic KLF4. Bar diagrams 
represent the mean value ± S.D. for three independent experiments. *p<0.05; 
**p<0.005, paired 2-tailed t test.  
 
3.5)  The Granulocyte- as well as the LC Populations are Inhibited by 
Ectopic KLF4 Expression  
 
KLF4 plays a role in inducing cell cycle arrest by inhibiting the Wnt/β-catenin 
signalling pathway and, therefore, consequently influences the proliferation of 
the cells (Zhang et al. 2006 Mol. Cell Biol.). Furthermore, it has been shown 
that KLF4 prevents apoptosis by up-regulating p21 (Ghaleb et al. Oncogene 
2007).  
Results 
 
 - 55 -  
We observed a significant reduction of the GFP+ positive cells in all 
experiments compared to the control. We detected the strongest reduction in 
the Gr and LC lineages (Figure 11). This can be due to the fact that KLF4 
plays a role in cell cycle arrest or because the cells are dying. We assessed 
this reduction in serum-free as well as in serum-containing differentiated 
KLF4 transduced cells. Interestingly, we realized a strong decrease of GFP+ 
cells even in Mo generation cultures, whereas the moDC as well as the intDC 
showed the slightest decrease. 
 
 
 
 
 
Figure 21: Cell populations with ectopic KLF4 are inhibited over time.  
RV-KLF4 GFP and empty CTRL vector transduced CD34+ cells were generated into 
the different lineages in serum-free or serum-containing media as described in 
material and methods. A) GFP+ cells were counted and bar diagrams show x-fold 
induction compared to empty CTRL vector transduced cells. ? White bars symbolize 
empty CTRL vector, ? black bars the RV-KLF4 GFP. Bar diagrams represent the 
mean value ± S.D. for three independent experiments. *p<0.05; **p<0.005 
***p<0.0005, paired 2-tailed t test. B) FACS blots of the GFP+ cell populations in the 
different generation cultures. The data shown represents one of three independent 
experiments with comparable results. 
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3.6)  Validation of Endogenous KLF4 Levels Shows an Inhibition in 
Monocyte-derived LC and an Increase in Monocyte-derived DC 
 
Previous studies indicate that inflammatory Mo in mouse give rise to LC after 
LC depletion (Ginhoux et al. Nat Immunol. 2006). In human skin, special 
CD16 positive Mo are able to produce LC (Schaerli et al. Immunity 2005). 
Building up on these data we hypothesized that KLF4 down-regulated is 
essential to induce LC development from Mo. We used a special culture 
condition system to generate LC from cord blood- (CBM) or peripheral blood 
Mo (PBM). In this system the Notch ligand Delta-1 as well as TGF-β1 are 
required to obtain LC-type DC (Hoshino et al. J Leukoc Biol. 2005). 
 
 
3.6.1)  Down-regulation of KLF4 under Delta-1 plus TGF-β1 
Conditions Favours a LC Phenotype which Shows LC 
Clusters 
 
We suggested that down-regulation of KLF4 is necessary to generate 
CD207/CD1a positive LC. TGF-β1 as well as Delta-1 are inhibitors of KLF4 
(Feinberg et al, J Biol Chem 2005; Ghaleb et al, Mol Cancer Res 2008). 
Apparently, it should also be possible to generate moLC without Delta-1 in 
conditions containing GM-CSF, IL-4 and TGF-β1 (Geißmann et al, J Exp 
Med. 1998).  
 
However, when we tried to generate moLC with GM-CSF, IL-4 and TGF-β1 
we observed a strong increase of the CD1a marker but only a little 
percentage of the cells developed into CD207 and CD1a double positive cells 
(Figure 22A, lower panel) without the typical LC cluster formations (Figure 
22B, lower picture). Therefore, we came to the conclusion that cells acquired 
more a moDC than a moLC phenotype under this condition.  
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In our hands only CBM that were cultivated with Delta-1 and TGF-β1 
developed into a CD207+ and CD1a+ cell population with typical LC cluster 
formations (Figure 22A and B, upper panel and picture). The cells retrained a 
monocytic phenotype when cultivated only in presence of TGF-β1. The cells 
showed no LC characteristics as well as no CD207/CD1a marker expression 
(Figure 22A and B, middle panel and middle picture).  
 
In the case of LC differentiation from Mo, TGF-β1 alone is not sufficient to 
induce LC commitment. Both Factors, TGF-β1 and Delta-1, are required for 
efficient moLC generation. Recent papers showed that KLF4 expression is 
inhibited via Notch signalling through its ligand Delta-1 (Zheng et al. 2008), 
which would further strengthens our hypothesis that KLF4 down-regulation is 
an essential process to obtain moLC. 
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Figure 22: LC development from Mo is absolutely depending on a 
combination of Delta-1 and TGF-β1.  
Isolated CBM were cultivated in serum containing media with GM-CSF, TGF-β1 and 
IL-4 or on dkαH-IgG coated plates with TGF-β1, GM-CSF and with and without Delta-
1 until day 7. A) Cells are analysed at day 7 for the indicated markers by FACS. B) 
Microscope pictures were taken at 10fold magnification at day 7. C) Statistical 
analysis of day 7; ? black bars symbolize the condition containing Delta-1; ? White 
bars the one without Delta-1; □ grey bars the TGF-β1, IL-4 and GM-CSF treated 
cells. Bar diagrams represent the mean value ± S.D. for three independent 
experiments. D) Cell lysates were analysed by western blot, actin served as a loading 
control. Data are representative of three independent experiments. 
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We checked endogenous KLF4 levels in the different conditions to assess 
whether Delta-1- and TGF-β1-dependent moLC development is accompanied 
by a down-regulation of KLF4 levels. As supposed, in conditions where we 
only added TGF-β1 we observed the presence of KLF4 levels. In contrast, 
combined addition of the Notch ligand Delta-1 and TGF-β1 showed absent 
KLF4 detection. This could be due to the fact that these two signalling 
pathways together strongly inhibit the expression of KLF4. In moDC or 
monocytic generation cultures we detected strong endogenous KLF4 levels 
(Figure 22D). 
 
3.6.2) IL-4 Up-regulates KLF4 Levels and thus Leads to the 
Generation of moDC 
 
We examined an inhibition of the LC pathway and a facilitation of Mo/moDC-
like phenotypes with ectopic KLF4. Hence, we proposed higher KLF4 protein 
levels in moDC compared to moLC. IL-4 was found to be absolutely 
necessary to obtain moDC from CBM (Chapuis et al, Eur J Immunol. 1997). 
Interestingly, we generated moDC instead of moLC in presence of IL-4 and 
TGF-β1. These cells differentiated with a high percentage to CD11b and 
CD1a double positive cells. Furthermore, nearly all cells developed were 
CD1a positive (Figure 22A, lower panel).  In contrast, nearly all cells cultured 
with IL-4 alone turned CD11b positive (Figure 23A and D). Independently of 
this different CD1a and CD11b expressions, the endogenous KLF4 levels 
remained the same under both conditions (Figure 23C) although we expected 
a decrease in the condition containing TGF-β. 
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Figure 23: Endogenous KLF4 levels are up-regulated in moDC under IL-4 
as well as under Il-4 plus TGF-β1 conditions.  
Isolated CBM were cultivated in serum containing media with GM-CSF and IL-4 or 
with GM-CSF, IL-4 and TGF-β1. A) FACS analysis of the cells at day 7 for the 
indicated markers in serum containing media with GM-CSF and IL-4. B) Microscope 
pictures were taken at 10fold magnification at day 7. C) Cell lysates were analysed 
by western blot, actin served as a loading control. Data are representative of three 
independent experiments. D) Statistical analysis of day 7; ? White bars the one with 
IL-4; ? black bars symbolize the condition containing IL-4 plus TGF-β1. Bar diagrams 
represent the mean value ± S.D. for three independent experiments. 
 
 
 
The generation of moDC from Mo also occurs in other conditions, involving 
TNFα, IL15 or IFNα. TNFα gives rise to a special moDC-like phenotype which 
has monocytic characteristics but also shows expression of CD1a (Iwamoto 
et al, J Immunol. 2007). IL-15 induces a CD1a positive cell population from 
Mo. Those cells loose CD14 but only half of the population gains CD11b. 
Interestingly, those cells are also reported to become CD207 positive 
Results 
 
 - 61 -  
(Mohamadzadeh et al, J Exp Med. 2001). In addition, it is reported that IFNα 
can also induce the development of CD1a positive cells from Mo (Santini et 
al, J Exp Med. 2000).  
 
We analyzed KLF4 expression under these conditions in PBM. We treated 
Mo with either IL15 or IFNα or TNFα and analyzed the generated cells for 
informative lineage markers as well as KLF4 protein expression levels. Under 
these different conditions we generated only a small CD1a/CD11b double 
positive cell population. Additionally, all cells developed very high CD11b 
expression levels which is characterizing for a monocytic/dendritic phenotype. 
Interestingly, we found a higher percentage of monocytic-like cells with IFNα 
than in the other conditions. Additionally, these cells revealed the existence of 
the monocytic marker CD14 (Figure 24A, lower panel). However, the cells 
failed to form clusters (Figure 24B, pictures on the right side), to acquire a LC 
phenotype or a CD11b/CD1a positive moDC-like population under these 
three different generation culture systems. In contrast, the cells acquired LC 
characteristics when generated with Delta-1 and TGF-β1 (Figure 24A, left 
side), formed LC clusters (Figure 24B, left side) and showed absent KLF4 
protein levels (Figure 24C). Additionally, the generation of moDC occurred 
under IL-4 influence (Figure 24A and B, left side). 
 
Assessment of endogenous KLF4 revealed less KLF4 protein levels in the 
IFNα condition, although these cells only acquired monocytic-like features. 
However, cells treated with TNFα or IL-15 revealed equalled KLF4 levels as 
in IL-4 situation (Figure 24C) although the generation of moDC failed under 
these conditions. KLF4 down-regulation occurred only in conditions with 
Delta-1 and TGF-β1. 
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Figure 24:  IL-4 is absolutely necessary to obtain moDC as well as Delta-
1 plus TGF-β1 is required to generate moLC.  
Isolated CD14+ cells from the peripheral blood (PBM) of three different donors were 
cultivated in serum containing media with GM-CSF plus IL-4 or IL-15 or IFNα or 
TNFα or on dkαHuIgG (donkey-anti-human IgG) coated plates with GM-CSF, Delta-1 
and TGF-β1 until day 7. A) FACS analysis at day 7, on the left site control FACS 
blots for moLC and moDC are shown. B) Microscope pictures were taken at 10fold 
magnification at day 7, on the left site control microscope pictures for moLC and 
moDC are shown. C) Cell lysates were analysed by western blot, actin served as a 
loading control. Data are representative for three individual donors. D) Statistical 
analysis of day 7; ? White bars the one with Delta-1 plus TGF-β1, a moLC control; ? 
black bars symbolize the condition containing IL-4, the moDC control. Bar diagrams 
represent the mean value ± S.D. from three different donors. 
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We recognized different expression profiles in the differentiation of cord blood 
Mo (CBM) compared to PBM in these conditions. We detected more 
monocytic-like cells with either TNFα or IFNα or IL-15. Additionally, the cells 
failed to develop a CD11b and CD1a double positive cell population (Figure 
25). 
 
. 
Figure 25: After different cytokine stimulation CBM develop another 
phenotype than PBM.  
CBM were cultivated in serum-containing media with GM-CSF plus IL-4 or IL-15 or 
IFNα or TNFα or on dkαHuIgG coated plates with GM-CSF, Delta-1 and TGF-β1 until 
day 7. The cells were analysed by FACS at day 7 and statistical analysis are shown 
in the bar diagrams; ? White bars represent the condition with Delta-1 plus TGF-β1, 
a moLC control; ? black bars symbolize the condition containing IL-4, the moDC 
control. Bar diagrams represent the mean value ± S.D. from two different donors. On 
the right side the results from PBM were shown as before (Figure 24D).
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4) Discussion 
 
Hematopoiesis is a well coordinated process which requires expression of 
distinct transcription factors. The myeloid lineages differentiate from HSC 
under the control of factors which activate or repress lineages specific target 
genes and thus drive lineage commitment. Ordered myelopoiesis relies on 
the correct expression pattern, the combination of specific factors and their 
coordinated interplay (Tenen et al, Blood 1997; Nerlov, Tenen and Graf, 
University Press 2001; Orkin SH, Nat Rev Genet. 2000). There are many 
factors known which seem to have an influence on myeloid sublineage 
expression, such as Id2 and RelB for DC, VDR and MafB for Mo, Gfi-1 and 
C/EBPε and α for Gr or Id2 and IRF8 genes for LC differentiation. However, 
there is no single factor known which is only expressed in the myeloid 
lineages and acts as a master transcription factor for myeloid cell fate and 
choice. Representing a sublineage of myeloid DC, LC differentiation similarly 
relies on a complex interplay of several transcription factors. The identity of 
these factors and their exact role in LC differentiation is currently only poorly 
understood. Our laboratory previously demonstrated that LC differentiation 
from hematopoietic progenitor cells is critically dependent on the cytokine 
TGF-β1. For in vitro LC differentiation, TGF-β1 has to cooperate with other 
cytokines and ligands such as GM-CSF and Delta-1. GM-CSF may be 
replaced by M-CSF, and TNFα plus FLT3L enhance LC differentiation. 
However, TGF-β downstream (co-)signalling is absolutely essential for LC 
differentiation.  This notion is supported by recent observations that Activin A, 
a TGF-β/BMP family member can replace TGF-β1 for LC differentiation. The 
goal of this project was to identify the critical transcription factor combinations 
that induce LC differentiation downstream of TGF-β1 signalling. 
 
Previous studies indicated KLF4 as an important factor for Mo development. It 
regulates the monocytic CD14 promoter as well as iNOS production in 
activated Mac (Feinberg et al, J Biol Chem 2005 and EMBO J 2007). It has 
also been shown that KLF4 acts either as tumor suppressor or oncogene 
(McConnell et al, Bioessays 2007) and regulates proliferation and apoptosis 
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(Zhang et al, Mol Cell Biol 2006; Ghaleb et al, Oncogene 2007). KLF4 
belongs to the Kruppel-like transcription factor family which contains three 
zinc fingers for DNA-binding and is implicated in a variety of physiological 
processes (Dang et al, Int J Biochem Cell Biol 2000).  
 
We used culture systems which allow us to generate different myeloid 
lineages from CD34+ cord blood progenitor cells. Additionally, certain DC 
subsets can also be generated in vitro from peripheral blood CD14+ Mo. The 
addition of specific cytokines drives the commitment into a distinct cell type 
which is identified by FACS for its lineage specific marker expression shown 
in Figure 3. We also infected the cells by using a retrovirus-mediated gene 
transfer system. Specifically, we studied the role of KLF4 in myeloid 
sublineage development. 
 
PU.1 expression is necessary for the development of the different DC 
subsets. Ectopic PU.1 expression promotes DC differentiation from 
hematopoietic progenitor cells; however, only in the presence of defined co-
signals. Importantly, TGF-β1 is required for LC differentiation from PU.1 
transduced progenitors. PU.1 is also able to activate KLF4 expression which 
is an important factor for Mo development (Feinberg et al, EMBO J 2007).  It 
is very interesting that one single factor such as PU.1 is essential for several 
different myeloid subsets and it is, therefore, unlikely that this factor alone is 
able to make a choice of cell fate. Other factors seem to be implicated in this 
selection process. We observed that KLF4 is expressed at much lower levels 
in LC compared to Mo/Mac and intDC, and that ectopic KLF4 abrogates LC 
differentiation, while promotes DC differentiation. Therefore, the repression of 
KLF4 seems to be functionally required for LC differentiation from monocytic 
cells, while it plays a positive role in DC differentiation. Our observations point 
to a model of LC lineage commitment, whereby TGF-β1 signalling represses 
KLF4. In vivo TGF-β1 within the epidermis provides the critical signal for LC 
differentiation from Mo. Therefore, KLF4 repression seems to enable Mo to 
differentiate to LC in the epidermis. During initial Mo differentiation PU.1 
seems to up-regulate KLF4 expression. Therefore, subsequent differentiation 
processes of monocytic cells into LC versus DC seem to be critically 
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regulated by KLF4 expression levels. Interestingly, PU.1-mediated KLF4 
induction during Mo differentiation might be the reason why PU.1 alone is not 
able to induce LC development as observed in previous studies. Although 
PU.1 is one of the necessary transcription factors for LC differentiation, PU.1 
requires TGF-β1 co-signalling for LC differentiation.  According to our model, 
TGF-β1-mediated repression of KLF4 may cooperate with PU.1 for inducting 
lineage specification of LC within the epidermis. 
 
Previous studies indicate that TGF-β1 antagonizes KLF4 and vice versa 
(Feinberg et al, J Biol Chem 2005) and we detected a strong reduction of 
KLF4 in CD34+ cells cultivated with TGF-β1 on RNA as well as on protein 
level (Figure 13B and C). LC and Gr showed little to no KLF4 protein 
expression whereas intDC and Mo clearly expressed KLF4. intDC showed 
among all myeloid cell subsets tested the highest KLF4 protein expression 
level (Figure 13C). They were generated from Mo in response to the cytokine 
signals GM-CSF, IL-4 and TNFα; GM-CSF is an important cytokine in 
inflammation and it seems as if it is involved in the development of 
“inflammatory” DC (Hamilton JA, Nat Rev Immunol 2008; Shortman et al, Nat 
Rev Immunol 2007). A special “inflammatory” DC subset is the Tip-DC which 
is characterised by its TNFα and iNOS production (Lowes et al, Proc Natl 
Acad Sci USA 2005). KLF4 is able to induce iNOS; considering these 
previous studies, DC generated in our system might better be termed 
“inflammatory” DC, given that these cells express higher KLF4 protein levels 
than other myeloid cell subsets. In comparison, in vitro generated M-CSF-
dependent Mo revealed lower KLF4 protein levels (Feinberg et al, EMBO J 
2007). It is therefore interesting to speculate that inflammatory stimuli induce 
KLF4, which in turn promotes inflammatory-type DC differentiation. 
Furthermore, we suggest that KLF4 is very important for the initiation of Mo 
differentiation but is not required any more after completing this process 
(Figure 19C). Therefore, further studies of KLF4 expression during Mo 
development are of particular interest. KLF4 might regulate the differentiation 
of inflammatory DC and Mo which are characterized by high expression levels 
of iNOS. 
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Ectopic KLF4 expression experiments in CD34+ cells indicated an 
involvement of KLF4 in the regulation of CD1a expression. Interestingly, 
ectopic KLF4 significantly drops CD1a expression density in cells cultivated 
with GM-CSF and TNFα. However, KLF4 did not seem to alternatively 
promote Mo differentiation from these cells, given that KLF4 did not 
significantly induce CD14 in these cells at day 5. Only at later culture time 
points we observed an increase in CD14 as well as CD11b indicative of Mo 
differentiation by KLF4 transduced cells (Figure 16). Under moDC generation 
conditions (GM-CSF plus IL-4), ectopic KLF4 promoted the differentiation into 
a monocytic-like DC subset which was different in marker expression levels 
than the CTRL DC subset. The expression pattern of the CD11b marker 
increased significantly with ectopic KLF4 whereas CD1a decreased (Figure 
17A). In sharp contrast in LC generation conditions, ectopic KLF4 prevented 
LC development as revealed from a significant loss of CD1a and CD207 
expression in favour of a monocytic phenotype (as indicated by enhanced 
CD14 as well as CD11b expression; Figure 17B). These results suggest that 
under LC conditions, when TGF-β1 is not able to repress ectopic KLF4 
anymore, the differentiation into a monocytic cell is favoured whereas under 
moDC generation culture another monocytic-like DC cell type is promoted. 
The availability of IL-4 or the proinflammatory cytokine TNFα in combination 
with high KLF4 protein levels seems to be a reason for that; TNFα and KLF4 
facilitate monocytic cells (Figure 26A) whereas IL-4 and KLF4 stimulate a 
type of “inflammatory” monocytic-like DC type (Figure 26B). The previous 
description that GM-CSF/IL-4-dependent moDC phenotypically resemble 
“inflammatory dendritic epidermal cells” (IDECs) (Wollenberg et al, J Invest 
Dermatol. 2002) is in line with this model. 
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Figure 26: KLF4 and its implication in Mo or DC differentiation.  
A) KLF4 transduced cells cultured under LC differentiation condition in the presence 
of TNFα and TGF-β1 fail to give rise to LC, but instead acquire a monocytic 
phenotype. B) Under moDC culture condition with IL-4 KLF4 transduced cells fail to 
develop into monocytic cells as might be expected from observations by Feinberg et 
al. Instead these cells give rise to moDC, as evidenced by the observed increase in 
CD11b and reduced CD1a expression. The interaction of KLF4 with either TNFα and 
TGF-β1 or IL-4 seems to be critical for this differentiation process. 
 
 
The high expression level of KLF4 and the presence of the proinflammatory 
cytokine TNFα might be a reason for some inflammatory diseases like RA. In 
this disease, TNFα occurs at high levels in the inflamed joints (Feldmann et 
al, Springer Semin Immunopathol. 1998). High levels of KLF4 can promote 
some sorts of over-reactive Mac and DC. It would be further interesting if high 
KLF4 expression influences the expression of other surface markers which 
are important for migration or T-cell stimulation or some other immune system 
function. Additionally, the examination if these types of Mac or DC are 
implicated in e.g. RA, atherosclerosis or psoriasis is also of particular interest. 
Therefore, there might be an awakening interest to examine if there is any 
change in the KLF4 expression in such diseases. 
 
The transcription factor PU.1 plays an important role in the development of 
myeloid subsets since high expression levels favour Mo and DC development 
whereas low levels facilitate Gr differentiation. PU.1 null mice lack all 
peripheral blood leukocytes and died of acute septicaemia within 48h 
(McKercher et al, EMBO J. 1996 and J Leukoc Biol. 1999). Feinberg et al. 
demonstrated that in fetal liver cells from PU.1-/- mice KLF4 expression is 
absent and that there are PU.1 binding sites on the KLF4 promoter. 
Interestingly when KLF4 is ectopically expressed in those PU.1-deficient cells, 
only the expression of the M-CSFR can be restored indicating its important 
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role in Mo development whereas when PU.1 is over expressed the M-CSFR 
as well as the G-CSFR are re-detectable (Feinberg et al, EMBO J 2007).  
 
We examined that the differentiation process of Mo remained constant when 
KLF4 was ectopically expressed. This might be due to the fact that even 
under normal culture conditions over 75% of generated cells exhibited a 
monocytic phenotype. Therefore, we analyzed KLF4 under sub-optimal Mo 
culture conditions. Hence, we omitted one of the essential cytokines for Mo 
differentiation, i.e. M-CSF. When M-CSF is absent we only detected a very 
low number of CD14 and CD11b double positive cells (~15%) compared to 
control cultures in presence of M-CSF (Figure 20). Ectopic KLF4 restored this 
failure of Mo generation in culture conditions missing M-CSF (Figure 20B) 
thus indicating that KLF4 acts downstream of M-CSF as strong inducer of Mo 
development. KLF4 restores the impact of M-CSF and therefore, reconstitutes 
Mo differentiation process when M-CSF is absent. It might be interesting if 
KLF4 is able to affect not only the expression of the M-CSFR and CD14 but 
also of other important Mo surface expression molecules, like CCR2 which is 
expressed on “inflammatory” but not on “resident” Mo. “Inflammatory” Mo 
reveal a stronger dependence on KLF4 than “resident” Mo. Interestingly, 
previous studies demonstrated that these “inflammatory” Mo replenishing the 
LC pool in the skin after LC depletion (Alder et al, J Immunol 2008; Ginhoux 
et al, Nat Immunol 2006). CCR2 as well as M-CSFR play an essential role for 
this migration process into the skin and the repopulation of the LC (Merad et 
al, Nat Immunol 2002; Ginhoux et al, Nat Immunol. 2006). Another important 
fact in this field is that Notch signalling is essential for LC differentiation from 
CD14+ progenitors. The Notch ligand Delta-1 in combination with TGF-β1 
triggers isolated CD14+ Mo to differentiate into LC (Hoshino et al, J Leukoc 
Biol 2005). It is demonstrated that Notch signalling interferes with KLF4 
expression (Ghaleb et al, Mol Cancer Res 2008). Therefore, it is surprising 
that Mo reveal a strong expression of Notch signalling receptors on their 
surface. When these receptors come into contact with their ligands the 
survival of Mo is inhibited under M-CSF influence whereas under GM-CSF 
stimulation they develop into DC-like phenotypes (Ohishi et al, Blood 2000 
and 2001). If additionally TGF-β1 is present, the cells develop LC 
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characteristics (Figure 7). The Notch ligand Delta-1 as well as TGF-β1 and 
GM-CSF are factors present in the skin environment in vivo (Hoshino et al, J 
Leukoc Biol 2005; Lowell et al, Curr Biol 2000). Figure 27 shows the interplay 
of the different cytokines and the transcription factor KLF4 in the various cell 
lineage differentiation processes. 
 
 
Figure 27: The involvement of KLF4 in the complex process of dendritic-
like or Langerhans-like cell differentiation.  
It is already known that TGF-β1 is an essential factor for LC development. However, 
during Mo to a LC differentiation TGF-β1 alone is not sufficient to induce LC 
development. An additional factor is required; Delta-1 which is a ligand for Notch 
signalling (Hoshino et al, J Leukoc Biol 2005). KLF4 is repressed by TGF-β1 as well 
as Delta-1, whereas KLF4 is able to interact with TGF-β1 signalling and inhibit it 
(Feinberg et al, J Biol Chem 2005; Ghaleb et al, Mol Cancer Res 2008). Our study 
indicates that KLF4 represses the differentiation process of LC whereas a special 
type of DC is favoured. Previous studies delineated at least two different Mo subsets 
in human as well as in mice. The first one is characterised by its expression of CCR2 
while the second expresses CCR5 as well as CX3CR1. The CCR2+ subset is known 
as “classical” (human) or “inflammatory” (mouse) subset and is shown to give rise to 
LCs whereas the CCR2- subset is the “proinflammatory” (human) or “resident” 
(mouse) subset which has a higher predisposition to develop into moDC (Grage-
Griebenow et al., Eur. J. Immunol. 2001; Randolph et al., J. Exp. Med. 2002; Ginhoux 
et al, Nat Immunol. 2006). MCP-1 is a ligand for CCR2; MIP-1α is the ligand for 
CCR5. 
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We revealed an absence of KLF4 in moLC (Figure 22D). CD14+ cells 
cultivated only with TGF-β1 and GM-CSF showed a monocytic phenotype 
(CD14+CD11b+) associated with high KLF4 expression, whereas cells 
generated with TGF-β1, Delta-1 and GM-CSF expressed CD207 and CD1a, 
formed LC clusters and lacked detectable KLF4 protein expression (Figure 
22). Interestingly, in all other conditions which were used to obtain a moDC-
like phenotype, KLF4 expression was present and only under Delta-1 plus 
TGF-β1 condition, cells showed LC characteristics and absent KLF4 protein 
expression (Figure 22 and 24). The interplay between Notch signalling and 
the TGF-β1 pathway is absolutely required for LC differentiation from a CD14+ 
precursors. Furthermore, exogenous Delta-1 is not required for LC 
differentiation from CD34+ precursors. It is attractive to speculate that these 
two factors have to act synergistically to allow the development into LC from 
fully differentiated Mo because several reports show a regulation of common 
target genes by Notch signalling and TGF-β1.  
 
A possible target gene might be KLF4 because it is demonstrated that both 
factors, TGF-β1 as well as the Notch signalling pathway, repress KLF4 
expression. In line with this, we failed to detect KLF4 in moLC (Figure 22). It 
is interesting to speculate that in CD34+ cells, where only low levels of KLF4 
are present, TGF-β1 alone is sufficient to suppress KLF4 expression and 
allow LC differentiation, while in fully differentiated Mo, which express higher 
levels of KLF4, the synergism between both Notch and TGF-β1 signalling is 
required to sufficiently repress KLF4 and allow LC development. In line with 
this, the addition of TGF-β1 alone to Mo is not able to suppress KLF4 protein 
expression or induce the development of LC-like cells. There seems to be a 
complicated interplay of transcription factors, signalling pathways and the 
expression of distinct surface receptors during Mo/DC subset development. 
We suppose that after Mo are infiltrating the skin KLF4 down-regulation is 
absolutely necessary to obtain LC. Notch- and TGF-β1 co-signalling mediates 
this KLF4 down-regulation. 
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Figure 28: KLF4 and its implication in LC development.  
LC can be generated from CD14+ Mo progenitor cells under the influence of Delta-1 
and TGF-β1. Both stimuli together repress KLF4. When KLF4 levels are very high a 
distinct pathway of monocytic cells develops. Depending on the cytokine influence 
these KLF4+ cells acquire moDC or Mac phenotype. 
 
 
Another interesting point is that the generation of DC-like cells in presence of 
GM-CSF with IL15, TNFα or IFNα failed, as demonstrated from other groups 
(Mohamadzadeh et al, J Exp Med 2001; Iwamoto et al, J Immunol 2007; 
Santini et al, J Exp Med 2000). IL15 should also be able to induce CD207 
expression but we were never able to demonstrate this (Figure 24). Why our 
peripheral blood isolated CD14+ cells did not develop such a DC-like 
phenotype remains elusive. We detected only low percentages of CD11b and 
CD1a double positive cells, whereas with IFNα more monocytic cells 
developed (Figure 24). Interestingly, when we tried the same with cord blood 
isolated CD14+ cells, nearly all cells developed monocytic-like features and 
did not gain CD1a (Figure 25). Maybe culture conditions still need to be 
further improved to develop these cell types with the described cytokine 
combinations. 
 
We found that Mo up-regulate KLF4 concomitant with moDC differentiation in 
response to G-CSF and IL-4 stimulation. Conversely, they down-regulate 
KLF4 during moLC differentiation induced by TGF-β1, Delta-1 and GM-CSF. 
It would be interesting to transfect Mo with ectopic KLF4 to provide further 
evidence that KLF4 repression is required for LC differentiation. We would 
expect an abolishment of moLC differentiation. Inversely, ectopic KLF4 in 
CD14+ cells may favour a type of “inflammatory” moDC, or alternatively 
Mo/Mac differentiation might be promoted. We would assume an increase in 
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some type of “inflammatory” moDC because of the high KLF4 protein levels in 
DC. 
 
Another interesting part is silencing studies for the assessment of the effect of 
KLF4 on the myeloid lineages. KLF4 silencing in Mo might promote the 
differentiation process into moLC without the presence of Delta-1 or TGF-β1. 
Another question would be the differentiation process of moDC and whether it 
still takes place or switches into a moLC phenotype with KLF4 silencing. It is 
interesting if it might be possible to generate LC in absence of TGF-β1, when 
KLF4 is silenced in CD34+, or if TGF-β1 remains still essential. Furthermore, 
we would expect an increase of Gr and LC because of their absent KLF4 
expression levels (Figure 13C). It seems as if KLF4 down-regulation is 
necessary for their differentiation. Our generated DC showed high protein 
levels and we termed them “inflammatory” DC but maybe without KLF4 some 
sort of immature or anti-inflammatory DC subset can be generated. Another 
interesting experiment would be to silence KLF4 during DC subset 
differentiation of Mo. KLF4 silencing in Mo may promote moLC differentiation 
under sub-optimal stimulation conditions (e.g. without Delta-1 or TGF-β1). 
Furthermore, it would be interesting to analyze whether KLF4 silencing 
impairs moDC differentiation. Since KLF4 is repressed by TGF-β1, KLF4 
silencing may allow LC differentiation in the absence of TGF-β1. Furthermore, 
granulopoiesis and LC differentiation might be facilitated as a consequence of 
diminished KLF4 expression levels (Figure 13C). moDCs generated in 
response to GM-CSF plus IL-4 showed high KLF4 protein levels and we 
termed them “inflammatory” DC. It will be interesting whether KLF4 silencing 
may convert these cells to a more immature or tolerogenic DC subset.  
 
An attractive point of future research will be to address whether Mac and DCs 
from inflammatory lesions express high levels of KLF4 and if the inhibition of 
elevated KLF4 expression has an anti-inflammatory effect. Maybe with low to 
absent KLF4 levels the cells switch from an inflammatory to a resident or 
tolerogenic state. Therefore KLF4 might represent an interesting therapeutic 
target in autoimmune-inflammatory diseases.  
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KLF4 seems to represent a key player in the transcription factor network that 
controls development of the mononuclear phagocytic and DC system (Figure 
29). KLF4 function seems to be important for DC as well as Mo/Mac 
differentiation whereas its down-regulation seems to be absolutely essential 
for Gr and LC differentiation. Interestingly, PU.1 was previously shown to 
directly induce KLF4 expression, and to promote LC differentiation when 
ectopically expressed in myeloid progenitor cells. However, we found that 
KLF4 is down-regulated during LC differentiation. Down-regulation of this 
important factor is mediated by TGF-β1 plus Delta-1, both indispensable 
signals for LC differentiation. Future studies will show whether therapeutic 
targeting of key transcription factors within this network may alter DC function 
for the control of immunity and tolerance. 
 
 
 
Figure 29: KLF4 and its implication in myeloid cell development.  
KLF4 is necessary for DC and Mo whereas its down-regulation is essential for LC 
and Gr. Whereas PU.1 is an inducer, TGF-β1 and Delta-1 are inhibitors of KLF4. It 
might be interesting if KLF4 is able to affect other transcription factors or if itself is 
influenced. 
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